word,tfidf
month,0.2604977388598411
disease,0.26022283896481735
cell,0.18515855849419696
cells,0.17827766611772342
week,0.16596226911231812
versus,0.15638391764712584
transplantation,0.15075409661182929
graft,0.15012856094124077
host,0.1351157048471167
12,0.12072838442358112
10,0.11760070607063862
stem,0.11634963472946161
inclusion,0.1144730277176961
mesenchymal,0.11414282643589813
anti,0.11384749204710759
stromal,0.11274230095815704
criteria,0.09663625796413461
severe,0.09320481491768699
uveitis,0.09132820790592147
days,0.08820052955297897
hematopoietic,0.08382177985885944
transplant,0.08319624418827094
milligrams,0.07881749449415142
survival,0.0769408874823859
randomized,0.07282732484253622
use,0.07212706210366569
acute,0.07193660211767787
systemic,0.07005999510591236
kilograms,0.06943445943532386
relapse,0.06880892376473537
efficacy,0.06862574840931299
24,0.06693231675296986
human,0.06630678108238135
bd,0.06582469745383082
infusion,0.06568124541179284
therapy,0.06505570974120434
arm,0.06443017407061584
response,0.06443017407061584
active,0.06380463840002733
primary,0.06380463840002733
refractory,0.06317910272943883
donor,0.06255356705885033
duration,0.06192803138826183
safety,0.061302495717673315
allogeneic,0.06092285828173703
rate,0.05942588870590781
weeks,0.05880035303531931
post,0.0562982103529653
phase,0.0562982103529653
added,0.0551981643671493
infection,0.05442160334119979
sponsor,0.05420215465290672
group,0.05317053200002278
analysis,0.05317053200002278
adverse,0.052544996329434275
secondary,0.052544996329434275
haplo,0.05129392498825727
marrow,0.05111917993754947
sclerosis,0.05111917993754947
endpoint,0.05111917993754947
16,0.05111917993754947
evaluate,0.05033784372641408
risks,0.04965835868112673
regimen,0.049551314918188864
included,0.049018391720937846
antigen,0.049018391720937846
chronic,0.04879178230590325
thymoglobulin,0.04797825730173842
paris,0.04761786624319676
follow,0.04754071096472625
design,0.047191728493513205
effect,0.04691760350432622
conditioning,0.04628963962354924
total,0.04628963962354924
overall,0.04628963962354924
30,0.045664103952960736
year,0.045664103952960736
following,0.045664103952960736
oral,0.04561867087706276
expected,0.04561867087706276
grade,0.04503856828237224
period,0.04503856828237224
prophylaxis,0.044832142068837545
data,0.04441303261178373
20,0.04441303261178373
incidence,0.04411655254884406
age,0.04404561326061233
high,0.04378749694119523
life,0.04378749694119523
ii,0.04378749694119523
assistance,0.04357774333241734
matched,0.043416289809973516
adalimumab,0.043416289809973516
free,0.043416289809973516
events,0.04316196127060673
intravenous,0.04316196127060673
skin,0.04271602707110298
ptcy,0.04265087579245119
associated,0.04191088992942972
cyclophosphamide,0.0413155015933619
effects,0.0413155015933619
reduced,0.04089949802771144
failure,0.04065981858825272
36,0.04061523885449136
mycophenolate,0.039326440411261
publique,0.038539911603035784
leukocyte,0.038514450637879734
infectious,0.038514450637879734
rituximab,0.03851056387515951
scientific,0.03851056387515951
informed,0.03851056387515951
consent,0.03781418789900919
reported,0.037532140235310193
tuberculosis,0.03749712798370794
virus,0.037319516318394794
prospective,0.037319516318394794
hospitalization,0.03711392516013865
methods,0.03643095640605206
compared,0.03641366242126811
justification,0.03640729990173677
40,0.03628106889413319
immune,0.03628106889413319
mofetil,0.036180325178360125
immunosuppressive,0.036180325178360125
18,0.035713399682397576
mortality,0.035713399682397576
objectives,0.03554239649370933
bone,0.03539379637013491
21,0.03539379637013491
quality,0.03502999755295618
unrelated,0.03502999755295618
injection,0.03502999755295618
score,0.035013136943527035
leukemia,0.034653836581366594
fludarabine,0.03460726756190968
effective,0.03460726756190968
site,0.034456820309353244
ap,0.034456820309353244
best,0.03440446188236768
remission,0.03440446188236768
50,0.03440446188236768
sct,0.03431287420465649
hospital,0.03431287420465649
objective,0.033820738753684465
vasculitis,0.03377892621177918
endpoints,0.03361261146578595
contraception,0.03344338441790168
multicenter,0.03344338441790168
complete,0.03315339054119067
treated,0.03315339054119067
19,0.03315339054119067
test,0.03315339054119067
history,0.03303420994545924
antibodies,0.03291234872691541
participation,0.03242994852645011
hp,0.03242994852645011
pharmacodynamic,0.03224768113723402
investigator,0.03221208598804487
prednisone,0.03221208598804487
stage,0.03221208598804487
main,0.031902319200013664
saa,0.03170958378538364
treosulfan,0.031461152329008805
participants,0.031461152329008805
national,0.031461152329008805
care,0.031276783529425166
25,0.030811560510303787
100,0.030811560510303787
function,0.030811560510303787
randomization,0.030651247858836658
intrauterine,0.030535154756295355
recently,0.030211037019652928
48,0.030111297771433246
tocilizumab,0.030111297771433246
anemia,0.030111297771433246
evidence,0.030025712188248156
specific,0.030025712188248156
increased,0.030025712188248156
cd,0.029888094712558363
funding,0.02936072572720707
busulfan,0.02936072572720707
compare,0.029322477107310195
comparing,0.029101565904333142
lung,0.029101565904333142
negative,0.029101565904333142
placebo,0.02877464084707115
visit,0.028710772293692163
13,0.02831503709610792
acronym,0.028186296698118788
abstinence,0.028186296698118788
involvement,0.02814910517648265
event,0.02814910517648265
monitoring,0.02801050955482163
statistical,0.02754535728262473
cases,0.02754535728262473
carcinoma,0.02754535728262473
22,0.027528508287882704
60,0.027523569505894144
health,0.027523569505894144
activity,0.027523569505894144
2019,0.027362769069192282
globulin,0.027362769069192282
major,0.027310246815951088
received,0.027310246815951088
insurance,0.027011867669030507
potential,0.026898033835305642
tnf,0.026898033835305642
renal,0.026741979479657483
positive,0.026741979479657483
women,0.026656797370281995
atlg,0.026656797370281995
recherche,0.026656797370281995
clinique,0.026656797370281995
pregnancy,0.026349333177740717
showed,0.026349333177740717
infections,0.026272498164717138
investigational,0.025955450671432262
adult,0.025909721338210005
population,0.025909721338210005
11,0.025909721338210005
covid,0.025909721338210005
doi,0.02583743863994222
administration,0.025646962494128636
coordinating,0.02533589728628915
il,0.02533589728628915
complications,0.025021426823540135
groups,0.025021426823540135
intensity,0.02487967754559653
ist,0.02466300961085394
sexual,0.02466300961085394
therapeutic,0.024509195860468923
baseline,0.024509195860468923
centre,0.024509195860468923
ref,0.02438239305498182
contraceptive,0.024322461394837583
agents,0.023991117633253796
monoclonal,0.023991117633253796
immunodeficiency,0.023991117633253796
identical,0.02380893312159838
organ,0.02380893312159838
ks,0.02380893312159838
long,0.02380893312159838
antibiotic,0.02380893312159838
treatments,0.023770355482363125
sample,0.023595864246756602
26,0.02348858058176566
sars,0.02314481981177462
ocular,0.02314481981177462
retinal,0.02314481981177462
observed,0.02314481981177462
80,0.02310867038272784
cancer,0.02310867038272784
assess,0.02310867038272784
term,0.02310867038272784
european,0.023102557720911063
medicinal,0.023102557720911063
controlled,0.023102557720911063
prevalence,0.023102557720911063
product,0.02280933543853138
benefit,0.02251928414118612
heart,0.0224084076438573
requiring,0.0224084076438573
methotrexate,0.022314151552677373
hepatitis,0.022295589611934452
promising,0.022295589611934452
centers,0.022295589611934452
demonstrated,0.022295589611934452
department,0.022295589611934452
28,0.02221399780856833
myeloid,0.02221399780856833
hospitalier,0.02221399780856833
similar,0.02221399780856833
pulmonary,0.022022806630306164
aplastic,0.022022806630306164
donors,0.022022806630306164
70,0.021893748470597614
cryoglobulinemia,0.021893748470597614
reduction,0.021708144904986758
drugs,0.021325437896225596
agent,0.021282153720482887
ric,0.021282153720482887
cardiac,0.021268212800009113
35,0.021236277822080943
hours,0.021236277822080943
improvement,0.021236277822080943
centres,0.021139722523589092
interventions,0.021139722523589092
yes,0.021139722523589092
sources,0.021139722523589092
higher,0.02100788216611622
17,0.02100788216611622
behcets,0.020642677129420608
eye,0.020642677129420608
common,0.02044974901385572
center,0.02044974901385572
haploidentical,0.02043687798388286
changes,0.02043687798388286
corticosteroids,0.02030761942724568
confirmed,0.02030761942724568
serum,0.02030761942724568
experimental,0.02030761942724568
inflammation,0.02030761942724568
hypersensitivity,0.02026871782903132
benefits,0.02026871782903132
pregnant,0.02026871782903132
end,0.020017141458832106
progression,0.020017141458832106
retrospective,0.019965293494500807
mud,0.0196632202056305
laherparepvec,0.0196632202056305
biological,0.0196632202056305
ml,0.0196632202056305
talimogene,0.0196632202056305
receiving,0.019607356688375138
inflammatory,0.019607356688375138
reference,0.019607356688375138
belimumab,0.019607356688375138
absence,0.019607356688375138
visual,0.019607356688375138
approach,0.019607356688375138
min,0.019548318071540127
fraction,0.019548318071540127
eligible,0.019548318071540127
breast,0.019548318071540127
exclusion,0.019548318071540127
management,0.019391605788243605
early,0.019391605788243605
optimal,0.019391605788243605
female,0.019255281937579756
device,0.019255281937579756
reactions,0.019255281937579756
ci,0.019255281937579756
nausea,0.019255281937579756
2020,0.019255281937579756
iii,0.018907093949504596
threatening,0.018907093949504596
tumor,0.018907093949504596
line,0.018907093949504596
international,0.018907093949504596
receive,0.01887669139740528
currently,0.01887669139740528
uncontrolled,0.01887669139740528
cov,0.01887669139740528
creatinine,0.01887669139740528
known,0.01887669139740528
aged,0.01887669139740528
reconstitution,0.01887669139740528
arms,0.01887669139740528
tcz,0.018790864465412525
mice,0.018790864465412525
cellular,0.018790864465412525
syndrome,0.018766070117655097
toxicity,0.018766070117655097
available,0.018766070117655097
levels,0.018766070117655097
considered,0.018766070117655097
hormonal,0.018659758159197397
strategy,0.018659758159197397
option,0.018659758159197397
published,0.018241846046128187
millimeter,0.018241846046128187
source,0.018206831210634055
status,0.018206831210634055
outcomes,0.018206831210634055
subject,0.018206831210634055
antibody,0.018206831210634055
previous,0.018206831210634055
peripheral,0.018140534447066595
assessed,0.018140534447066595
level,0.018140534447066595
aa,0.018090162589180062
saint,0.018090162589180062
programme,0.018090162589180062
prevent,0.017771198246854664
pain,0.017771198246854664
injectable,0.017616435436324244
corticosteroid,0.01751499877647809
outcome,0.01751499877647809
current,0.01751499877647809
count,0.01751499877647809
lesions,0.01751499877647809
assessment,0.01751499877647809
sparing,0.017506568471763517
sle,0.017506568471763517
aiec,0.017506568471763517
body,0.017506568471763517
terms,0.017506568471763517
sibling,0.01730363378095484
shown,0.01730363378095484
treat,0.01730363378095484
transplanted,0.01730363378095484
association,0.01730363378095484
95,0.01730363378095484
55,0.01688946310588959
increase,0.01688946310588959
steroid,0.01688946310588959
france,0.01688946310588959
resistant,0.01688263833451193
immunosuppression,0.01688263833451193
improve,0.01688263833451193
written,0.01688263833451193
extension,0.01688263833451193
mammography,0.01688263833451193
capacity,0.01688263833451193
combination,0.01688263833451193
despite,0.01688263833451193
thymocyte,0.01688263833451193
signed,0.01688263833451193
imaging,0.016806305732892976
louis,0.016806305732892976
need,0.016806305732892976
camostat,0.016806305732892976
size,0.016806305732892976
acuity,0.01651710497272962
05,0.01651710497272962
infliximab,0.01651710497272962
clearance,0.01651710497272962
respiratory,0.01651710497272962
aml,0.01651710497272962
biologics,0.01644200640723596
23,0.01644200640723596
cubic,0.01644200640723596
children,0.01644200640723596
society,0.01644200640723596
probability,0.016263927435301084
tomosynthesis,0.016214974263225056
older,0.016214974263225056
open,0.016214974263225056
childbearing,0.016214974263225056
head,0.016214974263225056
aes,0.016214974263225056
improved,0.016214974263225056
fibrosis,0.016214974263225056
highly,0.016214974263225056
evaluated,0.016106042994022435
engraftment,0.016106042994022435
simons,0.015994078422169197
median,0.015994078422169197
board,0.015994078422169197
diagnosis,0.015994078422169197
42,0.015994078422169197
profile,0.015730576164504403
recent,0.015730576164504403
impact,0.015730576164504403
corrected,0.015730576164504403
protein,0.015730576164504403
medical,0.015638391764712583
therapies,0.015405780255151894
pr,0.015405780255151894
usual,0.015405780255151894
obtained,0.015405780255151894
low,0.015405780255151894
single,0.015405780255151894
baltimore,0.015267577378147677
multicentre,0.015267577378147677
blindness,0.015267577378147677
ifx,0.015267577378147677
diarrhea,0.015267577378147677
power,0.015267577378147677
cd38,0.015201538371773491
reducing,0.015201538371773491
urinary,0.015201538371773491
significantly,0.015201538371773491
public,0.015201538371773491
small,0.015201538371773491
irradiation,0.015201538371773491
bayesian,0.015105518509826464
reaction,0.015105518509826464
vs,0.015105518509826464
subcutaneously,0.015105518509826464
administered,0.015105518509826464
myeloablative,0.015105518509826464
adults,0.015105518509826464
aminotransferase,0.015105518509826464
additional,0.015012856094124078
prca,0.015012856094124078
grfs,0.014944047356279182
lymphocyte,0.014944047356279182
expression,0.014944047356279182
disorders,0.014944047356279182
niu,0.014944047356279182
setting,0.014944047356279182
french,0.014944047356279182
better,0.014944047356279182
occurrence,0.014705517516281352
significant,0.014705517516281352
standardization,0.014705517516281352
mds,0.014705517516281352
macular,0.014387320423535575
acquired,0.014216958597483731
bilirubin,0.014216958597483731
amino,0.014216958597483731
alanine,0.014216958597483731
strong,0.014216958597483731
aspartate,0.014216958597483731
l1,0.014216958597483731
tissue,0.014216958597483731
stopped,0.014216958597483731
transferase,0.014216958597483731
old,0.014216958597483731
vitro,0.014188102480321924
fatigue,0.014188102480321924
shortening,0.014188102480321924
myelofibrosis,0.014188102480321924
37,0.014188102480321924
past,0.014188102480321924
morbidity,0.014188102480321924
biologic,0.014188102480321924
partner,0.014188102480321924
vaccine,0.014188102480321924
malignancy,0.014188102480321924
demonstrate,0.01415751854805396
tomography,0.01415751854805396
sided,0.014093148349059394
party,0.014093148349059394
thiotepa,0.014093148349059394
103,0.014093148349059394
progestogen,0.014093148349059394
dr,0.014093148349059394
myelodysplastic,0.014093148349059394
vascular,0.014005254777410815
symptoms,0.014005254777410815
factors,0.014005254777410815
change,0.014005254777410815
nomenclature,0.014005254777410815
classification,0.014005254777410815
45,0.014005254777410815
pembrolizumab,0.014005254777410815
presence,0.014005254777410815
comparison,0.014005254777410815
doses,0.013761784752947072
posterior,0.013761784752947072
red,0.013761784752947072
adequate,0.013370989739828741
addition,0.013370989739828741
initial,0.013370989739828741
conventional,0.013370989739828741
autoimmune,0.013370989739828741
mesylate,0.013370989739828741
role,0.013370989739828741
stopping,0.013370989739828741
context,0.013370989739828741
planned,0.013328398685140998
derived,0.013328398685140998
cd8,0.013328398685140998
2016,0.013304992038540273
2014,0.013304992038540273
viral,0.013304992038540273
manifestations,0.013304992038540273
2012,0.013304992038540273
transfusion,0.013304992038540273
young,0.013174666588870359
remains,0.013174666588870359
properties,0.013174666588870359
mmhg,0.013174666588870359
tract,0.013174666588870359
hôpitaux,0.013174666588870359
curative,0.013174666588870359
2018,0.013174666588870359
multi,0.013174666588870359
basal,0.013174666588870359
intestinal,0.013174666588870359
abnormalities,0.013174666588870359
short,0.013174666588870359
prognosis,0.013174666588870359
situ,0.013174666588870359
procedure,0.013136249082358569
concentration,0.013136249082358569
working,0.01291871931997111
recurrent,0.01291871931997111
biotherapies,0.01291871931997111
maladies,0.01291871931997111
live,0.01291871931997111
sites,0.012604729299669732
inhibitor,0.012604729299669732
selection,0.012604729299669732
isatuximab,0.012604729299669732
liver,0.012604729299669732
central,0.012604729299669732
required,0.012604729299669732
type,0.012604729299669732
la,0.01258446093160352
provide,0.01258446093160352
magnetic,0.01258446093160352
lupus,0.01258446093160352
recipient,0.01258446093160352
described,0.01258446093160352
weight,0.01258446093160352
decreased,0.01258446093160352
endemic,0.01258446093160352
106,0.01258446093160352
respectively,0.01258446093160352
resonance,0.01258446093160352
signs,0.012510713411770067
pre,0.012510713411770067
rates,0.012510713411770067
fever,0.012439838772798265
immunomodulatory,0.012439838772798265
sight,0.012439838772798265
approved,0.012439838772798265
mscs,0.012439838772798265
label,0.012439838772798265
interferon,0.012439838772798265
interventional,0.012439838772798265
pediatric,0.012439838772798265
psychiatric,0.012439838772798265
2005,0.012439838772798265
insufficiency,0.012161230697418791
committee,0.01190446656079919
transfusions,0.01190446656079919
ratio,0.01190446656079919
evaluation,0.01190446656079919
antibiotics,0.01190446656079919
mean,0.01190446656079919
cutaneous,0.01190446656079919
et,0.011885177741181563
second,0.011885177741181563
anterior,0.011885177741181563
poor,0.011885177741181563
steroids,0.011885177741181563
cure,0.011797932123378301
estimate,0.011797932123378301
lower,0.011797932123378301
repeated,0.011797932123378301
worsening,0.011797932123378301
injections,0.011797932123378301
underlying,0.011797932123378301
mismatch,0.011797932123378301
coherence,0.011797932123378301
cumulative,0.011797932123378301
interim,0.011797932123378301
maximum,0.011797932123378301
diseases,0.011797932123378301
practical,0.01174429029088283
protease,0.01174429029088283
blaise,0.01174429029088283
coverage,0.01174429029088283
31,0.01174429029088283
production,0.01174429029088283
sterilization,0.01174429029088283
series,0.01174429029088283
orally,0.011551278860455531
questionnaire,0.011551278860455531
induction,0.011551278860455531
malignancies,0.011551278860455531
inactive,0.011551278860455531
cohort,0.011551278860455531
hemoglobin,0.011551278860455531
2017,0.011551278860455531
rodnan,0.011551278860455531
deciliter,0.011551278860455531
equivalent,0.011551278860455531
summary,0.011551278860455531
forms,0.011551278860455531
upper,0.011551278860455531
participate,0.011551278860455531
edema,0.01125964207059306
date,0.01125964207059306
death,0.01125964207059306
evolution,0.01125964207059306
present,0.01120420382192865
report,0.01120420382192865
different,0.01120420382192865
tolerance,0.01120420382192865
classic,0.01120420382192865
ambulatory,0.011147794805967226
tumors,0.011147794805967226
article,0.011147794805967226
oedema,0.011147794805967226
york,0.011147794805967226
vomiting,0.011147794805967226
internal,0.011147794805967226
alpha,0.011147794805967226
hydroxyurea,0.011147794805967226
200,0.011147794805967226
sirolimus,0.011147794805967226
distinct,0.011147794805967226
cervix,0.011147794805967226
troubles,0.011147794805967226
enrolled,0.011011403315153082
allo,0.011011403315153082
combined,0.011011403315153082
abo,0.011011403315153082
medicine,0.011011403315153082
target,0.011011403315153082
pcr,0.011011403315153082
individuals,0.011011403315153082
left,0.011011403315153082
legal,0.010662718948112798
lines,0.010662718948112798
scd,0.010662718948112798
cost,0.010662718948112798
ventricular,0.010662718948112798
cyclosporine,0.010662718948112798
advanced,0.010662718948112798
men,0.010662718948112798
male,0.010662718948112798
chest,0.010662718948112798
plasma,0.010634106400004556
collection,0.010634106400004556
followed,0.010634106400004556
depletion,0.010569861261794546
transdermal,0.010569861261794546
scope,0.010569861261794546
grafts,0.010569861261794546
melanoma,0.010569861261794546
78,0.010569861261794546
tel,0.010569861261794546
antagonists,0.010569861261794546
email,0.010569861261794546
complicated,0.010569861261794546
pneumonia,0.010569861261794546
ius,0.010569861261794546
azathioprine,0.010569861261794546
asthenia,0.010569861261794546
curatorship,0.010569861261794546
good,0.01050394108305811
injected,0.01050394108305811
appendix,0.01050394108305811
reduce,0.01050394108305811
double,0.01050394108305811
partial,0.01050394108305811
exposed,0.01050394108305811
decrease,0.01050394108305811
graall,0.01022487450692786
optical,0.01022487450692786
lymphocytes,0.01022487450692786
absolute,0.01022487450692786
global,0.01022487450692786
measured,0.01022487450692786
2008,0.01022487450692786
kidney,0.01022487450692786
ebv,0.01022487450692786
hopital,0.01022487450692786
breastfeeding,0.01013435891451566
inclusions,0.01013435891451566
uti,0.01013435891451566
failed,0.01013435891451566
uc,0.01013435891451566
cooperative,0.01013435891451566
rationale,0.01013435891451566
2021,0.01013435891451566
stable,0.01013435891451566
suspected,0.01013435891451566
anakinra,0.01013435891451566
containing,0.01013435891451566
investigated,0.01013435891451566
chimerism,0.010008570729416053
infusions,0.009803678344187569
given,0.009803678344187569
counts,0.009803678344187569
performance,0.009803678344187569
point,0.009803678344187569
intensive,0.009803678344187569
des,0.009803678344187569
scale,0.009803678344187569
lymphoma,0.009774159035770063
inhibition,0.009774159035770063
large,0.009774159035770063
mainly,0.009774159035770063
action,0.009774159035770063
abnormal,0.009774159035770063
schedule,0.009774159035770063
2015,0.009774159035770063
ciprofloxacin,0.009774159035770063
prevention,0.009774159035770063
ktr,0.009774159035770063
oncology,0.009774159035770063
cd4,0.009774159035770063
ct,0.009774159035770063
general,0.00943834569870264
65,0.00943834569870264
terminology,0.00943834569870264
hypertension,0.00943834569870264
aims,0.00943834569870264
screening,0.00943834569870264
analyses,0.00943834569870264
sarcoma,0.00943834569870264
clinically,0.00943834569870264
difference,0.00943834569870264
twice,0.00943834569870264
bmt,0.00943834569870264
intermediate,0.00943834569870264
procedures,0.00943834569870264
grafalon,0.00943834569870264
led,0.009395432232706263
cbt,0.009395432232706263
copy,0.009395432232706263
remain,0.009395432232706263
30ml,0.009395432232706263
pathway,0.009395432232706263
weekly,0.009395432232706263
hbv,0.009395432232706263
reproductive,0.009395432232706263
52,0.009395432232706263
resolved,0.009395432232706263
security,0.009395432232706263
ag,0.009395432232706263
affiliation,0.009395432232706263
detect,0.009395432232706263
odv,0.009395432232706263
multiple,0.009383035058827548
rare,0.009120923023064094
dysfunction,0.009120923023064094
umbilical,0.009120923023064094
situation,0.009120923023064094
eastern,0.009120923023064094
cord,0.009120923023064094
initially,0.009120923023064094
progressive,0.009120923023064094
preferred,0.009120923023064094
pyelonephritis,0.009120923023064094
carbon,0.009120923023064094
cdeis,0.009120923023064094
tnfa,0.009120923023064094
indication,0.009120923023064094
auto,0.009120923023064094
conducted,0.009120923023064094
monoxide,0.009120923023064094
needed,0.009120923023064094
normal,0.009103415605317028
proportion,0.009103415605317028
recommended,0.009103415605317028
minimal,0.009103415605317028
neurological,0.009103415605317028
laboratory,0.009103415605317028
social,0.008885599123427332
stenosis,0.008885599123427332
hepatic,0.008885599123427332
intravenously,0.008885599123427332
unless,0.008885599123427332
arterial,0.008885599123427332
lack,0.008885599123427332
outside,0.008885599123427332
products,0.008885599123427332
plus,0.008885599123427332
rejection,0.008885599123427332
120,0.008885599123427332
illness,0.008885599123427332
neutropenia,0.008885599123427332
idiopathic,0.008885599123427332
immunosuppressants,0.008885599123427332
cervical,0.008885599123427332
observational,0.008885599123427332
development,0.008885599123427332
superior,0.008885599123427332
daily,0.008757499388239045
modified,0.008757499388239045
measures,0.008757499388239045
model,0.008757499388239045
severity,0.008757499388239045
performans,0.00865181689047742
platelets,0.00865181689047742
nervous,0.00865181689047742
80mg,0.00865181689047742
method,0.00865181689047742
responders,0.00865181689047742
initiation,0.00865181689047742
limit,0.00865181689047742
identified,0.00865181689047742
costs,0.008403152866446488
platelet,0.008403152866446488
iron,0.008403152866446488
course,0.008403152866446488
chamber,0.008403152866446488
allow,0.008403152866446488
2013,0.008403152866446488
onset,0.008403152866446488
withdrawal,0.008403152866446488
mismatched,0.00822100320361798
mondor,0.00822100320361798
81,0.00822100320361798
literature,0.00822100320361798
clinicaltrials,0.00822100320361798
tubal,0.00822100320361798
88,0.00822100320361798
000,0.00822100320361798
baff,0.00822100320361798
csm,0.00822100320361798
behalf,0.00822100320361798
behcet,0.00822100320361798
caused,0.00822100320361798
pitie,0.00822100320361798
rares,0.00822100320361798
reactivation,0.00822100320361798
salpetriere,0.00822100320361798
hypothesize,0.00822100320361798
registered,0.00822100320361798
cyp2c19,0.00822100320361798
releasing,0.00822100320361798
ophthalmology,0.00822100320361798
route,0.00822100320361798
significance,0.00822100320361798
aim,0.00822100320361798
solid,0.00822100320361798
hematology,0.00822100320361798
obstruction,0.00822100320361798
hcv,0.00822100320361798
supportive,0.00822100320361798
intravaginal,0.00822100320361798
samples,0.008131963717650542
resolution,0.008131963717650542
vessel,0.008131963717650542
value,0.008131963717650542
quantitative,0.008107487131612528
ovulation,0.008107487131612528
eu,0.008107487131612528
pharmacokinetic,0.008107487131612528
permanent,0.008107487131612528
diffusing,0.008107487131612528
ray,0.008107487131612528
2x106,0.008107487131612528
44,0.008107487131612528
5mg,0.008107487131612528
synthetic,0.008107487131612528
emergency,0.008107487131612528
excipients,0.008107487131612528
27,0.008107487131612528
2010,0.008107487131612528
code,0.008107487131612528
expert,0.008107487131612528
serology,0.008107487131612528
regulation,0.008107487131612528
spinal,0.008107487131612528
lifestyle,0.008107487131612528
evaluating,0.008107487131612528
hcg,0.008107487131612528
squamous,0.008107487131612528
requires,0.008107487131612528
dependent,0.008107487131612528
sepsis,0.008107487131612528
range,0.007997039211084599
inferiority,0.007997039211084599
bilateral,0.007997039211084599
condition,0.007997039211084599
rules,0.007997039211084599
rifaximin,0.007997039211084599
medication,0.007997039211084599
direct,0.007997039211084599
40mg,0.007997039211084599
undergoing,0.007997039211084599
disorder,0.007997039211084599
mild,0.007997039211084599
alternative,0.007997039211084599
ecog,0.007865288082252201
estimated,0.007865288082252201
values,0.007865288082252201
surface,0.007865288082252201
needs,0.007865288082252201
300,0.007865288082252201
29,0.007865288082252201
induced,0.007865288082252201
hydrogen,0.007865288082252201
acs,0.007865288082252201
rapid,0.007865288082252201
institute,0.007865288082252201
pan,0.007865288082252201
pressure,0.007865288082252201
blinded,0.007865288082252201
particular,0.007865288082252201
ion,0.007865288082252201
meeting,0.007865288082252201
white,0.007865288082252201
factor,0.007702890127575947
overload,0.007702890127575947
able,0.007702890127575947
support,0.007702890127575947
responses,0.007702890127575947
eligibility,0.007702890127575947
composite,0.007702890127575947
previously,0.007506428047062039
characteristics,0.007506428047062039
interval,0.007506428047062039
colonized,0.0071084792987418655
rank,0.0071084792987418655
apn,0.0071084792987418655
leakage,0.0071084792987418655
recipients,0.0071084792987418655
targets,0.0071084792987418655
characterize,0.0071084792987418655
question,0.0071084792987418655
inform,0.0071084792987418655
sampling,0.0071084792987418655
sf,0.0071084792987418655
diagnosed,0.0071084792987418655
109,0.0071084792987418655
affect,0.0071084792987418655
stratified,0.0071084792987418655
identify,0.0071084792987418655
lead,0.0071084792987418655
fluid,0.0071084792987418655
echocardiography,0.0071084792987418655
dosage,0.0071084792987418655
forced,0.0071084792987418655
fertility,0.0071084792987418655
glomerular,0.0071084792987418655
gov,0.0071084792987418655
arthritis,0.0071084792987418655
persistent,0.0071084792987418655
college,0.0071084792987418655
prescribed,0.0071084792987418655
blind,0.0071084792987418655
urine,0.0071084792987418655
poorly,0.007094051240160962
periods,0.007094051240160962
ebmt,0.007094051240160962
healthy,0.007094051240160962
delay,0.007094051240160962
regardless,0.007094051240160962
subcutaneous,0.007094051240160962
achieve,0.007094051240160962
substance,0.007094051240160962
superiority,0.007094051240160962
suggest,0.007094051240160962
allogenic,0.007094051240160962
affiliated,0.007094051240160962
allowed,0.007094051240160962
162,0.007094051240160962
sole,0.007094051240160962
allergic,0.007094051240160962
nih,0.007094051240160962
specifically,0.007094051240160962
receptor,0.007094051240160962
participated,0.007094051240160962
43,0.007094051240160962
individual,0.007094051240160962
cerebro,0.007094051240160962
regarding,0.007094051240160962
dramatically,0.007094051240160962
91,0.007094051240160962
isolated,0.007094051240160962
cancers,0.007094051240160962
confirm,0.007094051240160962
clonal,0.007094051240160962
frequent,0.007094051240160962
feeding,0.007094051240160962
proposed,0.00707875927402698
protection,0.00707875927402698
detected,0.00707875927402698
analyzed,0.00707875927402698
entry,0.00707875927402698
american,0.00707875927402698
180,0.00707875927402698
vital,0.00707875927402698
potentially,0.00707875927402698
discontinuation,0.00707875927402698
cytokine,0.00707875927402698
damage,0.00707875927402698
team,0.00707875927402698
gene,0.00707875927402698
consecutive,0.00707875927402698
cytokines,0.00707875927402698
toxicities,0.00707875927402698
rapidly,0.00707875927402698
eyes,0.00707875927402698
biopsy,0.00707875927402698
condoms,0.007046574174529697
cocktail,0.007046574174529697
addressing,0.007046574174529697
elt,0.007046574174529697
compounds,0.007046574174529697
selected,0.007046574174529697
valid,0.007046574174529697
haematopoietic,0.007046574174529697
pnh,0.007046574174529697
permitted,0.007046574174529697
unwilling,0.007046574174529697
blys,0.007046574174529697
fda,0.007046574174529697
38,0.007046574174529697
5xuln,0.007046574174529697
parenteral,0.007046574174529697
parents,0.007046574174529697
publication,0.007046574174529697
47,0.007046574174529697
pro,0.007046574174529697
multicentric,0.007046574174529697
transient,0.007046574174529697
infected,0.007046574174529697
75010,0.007046574174529697
adipose,0.007046574174529697
largely,0.007046574174529697
debilitating,0.007046574174529697
chru,0.007046574174529697
hemorrhagic,0.007046574174529697
envelope,0.007046574174529697
barrier,0.007046574174529697
child,0.007046574174529697
abuse,0.007046574174529697
cystitis,0.007046574174529697
cyp2d6,0.007046574174529697
abscess,0.007046574174529697
nk,0.007002627388705407
residual,0.007002627388705407
biopsies,0.007002627388705407
visits,0.007002627388705407
right,0.007002627388705407
neutrophil,0.007002627388705407
considering,0.007002627388705407
cause,0.007002627388705407
met,0.006880892376473536
unit,0.006880892376473536
vitreous,0.006880892376473536
greater,0.006880892376473536
recommendations,0.006880892376473536
cov2,0.006302364649834866
parameters,0.006302364649834866
percentage,0.006302364649834866
presented,0.006302364649834866
haze,0.006302364649834866
delayed,0.006302364649834866
regulatory,0.006302364649834866
spartalizumab,0.006302364649834866
late,0.006302364649834866
index,0.006302364649834866
release,0.006302364649834866
possible,0.00629223046580176
moderate,0.00629223046580176
relapses,0.00629223046580176
directly,0.00629223046580176
genetic,0.00629223046580176
reactive,0.00629223046580176
future,0.00629223046580176
developed,0.00629223046580176
hematological,0.00629223046580176
like,0.00629223046580176
immunological,0.00629223046580176
chemotherapy,0.00629223046580176
occurs,0.00629223046580176
elderly,0.00629223046580176
2003,0.00629223046580176
computed,0.00629223046580176
endoscopic,0.00629223046580176
voc,0.00629223046580176
capmatinib,0.006255356705885034
step,0.006255356705885034
equal,0.006219919386399132
alloimmunization,0.006219919386399132
markers,0.006219919386399132
safe,0.006219919386399132
segment,0.006219919386399132
sante,0.006219919386399132
adenocarcinoma,0.006219919386399132
shall,0.006219919386399132
ejection,0.006219919386399132
sustained,0.006219919386399132
tested,0.006219919386399132
carried,0.006219919386399132
optimized,0.006219919386399132
contraindication,0.006219919386399132
antidepressant,0.006219919386399132
cd20,0.006219919386399132
diabetes,0.006219919386399132
experience,0.006219919386399132
experienced,0.006219919386399132
prognostic,0.006219919386399132
accordance,0.006219919386399132
bacteria,0.006219919386399132
54,0.006219919386399132
physician,0.006219919386399132
150,0.006219919386399132
diffuse,0.006219919386399132
excluded,0.006219919386399132
condom,0.006080615348709396
sealed,0.006080615348709396
hospitalized,0.006080615348709396
sodium,0.006080615348709396
dependence,0.006080615348709396
willingness,0.006080615348709396
sickle,0.006080615348709396
alive,0.006080615348709396
vessels,0.006080615348709396
filtration,0.006080615348709396
field,0.006080615348709396
ultrasound,0.006080615348709396
normalization,0.006080615348709396
consistent,0.006080615348709396
prolonged,0.006080615348709396
program,0.006080615348709396
participating,0.006080615348709396
various,0.006080615348709396
particularly,0.006080615348709396
eventually,0.006080615348709396
mentioned,0.006080615348709396
pneumonitis,0.006080615348709396
metabolism,0.006080615348709396
34,0.006080615348709396
inspired,0.006080615348709396
2009,0.006080615348709396
vh,0.006080615348709396
02,0.006080615348709396
inferior,0.006080615348709396
thickness,0.006080615348709396
72,0.006080615348709396
documents,0.006080615348709396
avenue,0.006080615348709396
incidences,0.006080615348709396
hbs,0.006080615348709396
relapsing,0.006080615348709396
reviewed,0.006080615348709396
deficiency,0.006080615348709396
anticipated,0.006080615348709396
rna,0.006080615348709396
suggesting,0.006080615348709396
cataract,0.006080615348709396
gastrointestinal,0.006080615348709396
grading,0.006080615348709396
recruiting,0.006080615348709396
propose,0.006080615348709396
mra,0.006080615348709396
log,0.006080615348709396
list,0.006080615348709396
leading,0.006080615348709396
increasing,0.006080615348709396
apply,0.006080615348709396
appendices,0.006080615348709396
league,0.006080615348709396
guidelines,0.006080615348709396
cdai,0.006080615348709396
rheumatism,0.006080615348709396
transaminases,0.006080615348709396
trsae,0.006080615348709396
provides,0.006080615348709396
56,0.006080615348709396
madrs,0.005872145145441415
consultation,0.005872145145441415
consistently,0.005872145145441415
solution,0.005872145145441415
willing,0.005872145145441415
vaccines,0.005872145145441415
venlafaxine,0.005872145145441415
vasectomised,0.005872145145441415
consortium,0.005872145145441415
man,0.005872145145441415
microbiological,0.005872145145441415
anaemia,0.005872145145441415
presenting,0.005872145145441415
visceral,0.005872145145441415
2n,0.005872145145441415
understanding,0.005872145145441415
farge,0.005872145145441415
modalities,0.005872145145441415
intercourse,0.005872145145441415
creteil,0.005872145145441415
na,0.005872145145441415
randomised,0.005872145145441415
recruitment,0.005872145145441415
assays,0.005872145145441415
transplants,0.005872145145441415
focus,0.005872145145441415
drastically,0.005872145145441415
firm,0.005872145145441415
omeprazole,0.005872145145441415
cytopenias,0.005872145145441415
difficult,0.005872145145441415
guardianship,0.005872145145441415
options,0.005872145145441415
acting,0.005872145145441415
implantable,0.005872145145441415
optimize,0.005872145145441415
fulfilling,0.005872145145441415
symptomatic,0.005872145145441415
rct,0.005872145145441415
sustainable,0.005872145145441415
reading,0.005872145145441415
autologous,0.005872145145441415
rabbit,0.005872145145441415
paroxysmal,0.005872145145441415
50ml,0.005872145145441415
naive,0.005872145145441415
nct02213705,0.005872145145441415
little,0.005872145145441415
mucocutaneous,0.005872145145441415
kroger,0.005872145145441415
types,0.005872145145441415
tutorship,0.005872145145441415
bichat,0.005872145145441415
bearing,0.005872145145441415
information,0.00562982103529653
calculated,0.005602101910964325
completed,0.005602101910964325
33,0.005602101910964325
surgery,0.005602101910964325
syndromes,0.005602101910964325
testing,0.005602101910964325
section,0.005505701657576541
enrolment,0.005505701657576541
hypothesis,0.005505701657576541
search,0.005505701657576541
cerebral,0.005505701657576541
discontinued,0.005505701657576541
hemolytic,0.005505701657576541
allows,0.005505701657576541
observations,0.005505701657576541
criterion,0.005505701657576541
final,0.005505701657576541
extra,0.005505701657576541
practice,0.005505701657576541
involving,0.005505701657576541
01,0.005505701657576541
correlation,0.005331359474056399
panel,0.005331359474056399
rheumatology,0.005331359474056399
organs,0.005331359474056399
length,0.005331359474056399
lesion,0.005331359474056399
intervention,0.005331359474056399
appears,0.005331359474056399
2011,0.005331359474056399
prednisolone,0.005331359474056399
examinations,0.005331359474056399
necessary,0.005331359474056399
success,0.005331359474056399
metastatic,0.005331359474056399
birth,0.005331359474056399
dependency,0.005331359474056399
metabolic,0.005331359474056399
acceptable,0.005331359474056399
records,0.005331359474056399
unique,0.005331359474056399
birads,0.005331359474056399
definition,0.005331359474056399
binary,0.005331359474056399
discretion,0.005331359474056399
targeting,0.005331359474056399
colon,0.005331359474056399
proven,0.005331359474056399
nb,0.005331359474056399
cmv,0.005331359474056399
basis,0.005331359474056399
proteinuria,0.005331359474056399
lee,0.00506717945725783
reticulocytes,0.00506717945725783
vellefaux,0.00506717945725783
brands,0.00506717945725783
market,0.00506717945725783
relation,0.00506717945725783
expressed,0.00506717945725783
lowest,0.00506717945725783
address,0.00506717945725783
magic,0.00506717945725783
replete,0.00506717945725783
philadelphia,0.00506717945725783
enterobacteriaceae,0.00506717945725783
bacterial,0.00506717945725783
activated,0.00506717945725783
preventing,0.00506717945725783
feasibility,0.00506717945725783
chu,0.00506717945725783
digital,0.00506717945725783
92,0.00506717945725783
unable,0.00506717945725783
microbiota,0.00506717945725783
occlusion,0.00506717945725783
standardized,0.00506717945725783
md,0.00506717945725783
centralized,0.00506717945725783
demyelinating,0.00506717945725783
ig,0.00506717945725783
preinclusion,0.00506717945725783
htlv,0.00506717945725783
household,0.00506717945725783
occur,0.00506717945725783
subsequent,0.00506717945725783
ac,0.00506717945725783
reached,0.00506717945725783
linked,0.00506717945725783
error,0.00506717945725783
erythematosus,0.00506717945725783
l2,0.00506717945725783
kaposis,0.00506717945725783
topical,0.00506717945725783
monthly,0.00506717945725783
claude,0.00506717945725783
classical,0.00506717945725783
issues,0.00506717945725783
segmental,0.00506717945725783
alloreactive,0.00506717945725783
anaphylactic,0.00506717945725783
continued,0.00506717945725783
1mg,0.00506717945725783
order,0.005004285364708027
frequency,0.004901839172093784
cycles,0.004901839172093784
kaposi,0.004901839172093784
review,0.004901839172093784
neutrophils,0.004901839172093784
exposure,0.004901839172093784
hospitalizations,0.004901839172093784
historical,0.004901839172093784
ileal,0.004901839172093784
tolerated,0.00471917284935132
49,0.00471917284935132
dna,0.00471917284935132
account,0.00471917284935132
meet,0.00471917284935132
determine,0.00471917284935132
recommendation,0.00471917284935132
replacement,0.00471917284935132
cycle,0.00471917284935132
especially,0.00471917284935132
allowing,0.00471917284935132
500,0.00471917284935132
person,0.00471917284935132
candidate,0.00471917284935132
measurement,0.00471917284935132
biomarkers,0.00471917284935132
du,0.00471917284935132
adaptive,0.00471917284935132
artery,0.004697716116353131
advance,0.004697716116353131
agree,0.004697716116353131
interfere,0.004697716116353131
affecting,0.004697716116353131
simplicity,0.004697716116353131
infarction,0.004697716116353131
lymphoblastic,0.004697716116353131
luznik,0.004697716116353131
resting,0.004697716116353131
vasectomy,0.004697716116353131
consult,0.004697716116353131
calcineurin,0.004697716116353131
anticipate,0.004697716116353131
robin,0.004697716116353131
pathogenesis,0.004697716116353131
rt,0.004697716116353131
lateral,0.004697716116353131
correctly,0.004697716116353131
rubi,0.004697716116353131
sas,0.004697716116353131
evaluations,0.004697716116353131
ar,0.004697716116353131
v0,0.004697716116353131
postero,0.004697716116353131
represents,0.004697716116353131
aggravation,0.004697716116353131
continuation,0.004697716116353131
altered,0.004697716116353131
vegf,0.004697716116353131
empirical,0.004697716116353131
parallel,0.004697716116353131
effector,0.004697716116353131
logrank,0.004697716116353131
covid19,0.004697716116353131
likely,0.004697716116353131
seropositivity,0.004697716116353131
resistance,0.004697716116353131
lives,0.004697716116353131
exact,0.004697716116353131
cd34,0.004697716116353131
express,0.004697716116353131
uvb,0.004697716116353131
slow,0.004697716116353131
heterosexual,0.004697716116353131
reach,0.004697716116353131
assuming,0.004697716116353131
herpes,0.004697716116353131
comparatively,0.004697716116353131
favorable,0.004697716116353131
hypotheses,0.004697716116353131
occurred,0.004697716116353131
far,0.004697716116353131
methylprednisolone,0.004697716116353131
devastating,0.004697716116353131
miami,0.004697716116353131
characterization,0.004697716116353131
certain,0.004697716116353131
chance,0.004697716116353131
acts,0.004697716116353131
fai2r,0.004697716116353131
conceive,0.004697716116353131
inadequate,0.004697716116353131
opportunity,0.004697716116353131
redness,0.004697716116353131
offers,0.004697716116353131
strategies,0.004697716116353131
recovered,0.004697716116353131
ileocolonoscopies,0.004697716116353131
member,0.004697716116353131
mediated,0.004697716116353131
characterized,0.004697716116353131
hemoglobinuria,0.004697716116353131
truly,0.004697716116353131
territory,0.004697716116353131
raising,0.004697716116353131
therapeutically,0.004697716116353131
mol,0.004697716116353131
favour,0.004697716116353131
tapering,0.004697716116353131
87,0.004697716116353131
differences,0.004697716116353131
produce,0.004697716116353131
devillier,0.004697716116353131
supporting,0.004697716116353131
tacrolimus,0.004697716116353131
supplementary,0.004697716116353131
flexibility,0.004697716116353131
dosing,0.004697716116353131
mirna,0.004697716116353131
39,0.004697716116353131
million,0.004697716116353131
dominique,0.004697716116353131
thrombopenia,0.004697716116353131
mrna,0.004697716116353131
muscle,0.004697716116353131
baron,0.004697716116353131
gfr,0.004697716116353131
53,0.004697716116353131
10mg,0.004697716116353131
encouraging,0.004697716116353131
yielded,0.004697716116353131
younger,0.004697716116353131
pbsc,0.004697716116353131
06,0.004697716116353131
rule,0.004442799561713666
pga,0.004442799561713666
eltrombopag,0.004442799561713666
physical,0.004442799561713666
affected,0.004442799561713666
pt,0.004442799561713666
59,0.004442799561713666
invasive,0.004442799561713666
thrombocytopenia,0.004442799561713666
effectiveness,0.004442799561713666
tolerability,0.004442799561713666
nasal,0.004442799561713666
joint,0.004442799561713666
scan,0.004442799561713666
microns,0.004442799561713666
actg,0.004442799561713666
comply,0.004442799561713666
85,0.004442799561713666
registry,0.004442799561713666
important,0.004442799561713666
state,0.004442799561713666
attenuated,0.004442799561713666
sub,0.004442799561713666
features,0.004442799561713666
medicines,0.004442799561713666
angiography,0.004442799561713666
hhv8,0.004442799561713666
recovery,0.004442799561713666
preexisting,0.004442799561713666
400,0.004442799561713666
immunotherapy,0.004442799561713666
targeted,0.004442799561713666
conditions,0.004442799561713666
numbers,0.004442799561713666
inference,0.004442799561713666
earlier,0.004442799561713666
died,0.004442799561713666
digestive,0.004442799561713666
average,0.004442799561713666
growth,0.004442799561713666
sensitivity,0.004378749694119523
independent,0.004378749694119523
adapted,0.004378749694119523
place,0.004201576433223244
limited,0.004201576433223244
start,0.004201576433223244
obtain,0.004201576433223244
measure,0.004201576433223244
st,0.004053743565806264
agency,0.004053743565806264
knowledge,0.004053743565806264
pcra,0.004053743565806264
pd1,0.004053743565806264
percent,0.004053743565806264
1121,0.004053743565806264
quantiferon,0.004053743565806264
antiviral,0.004053743565806264
physicians,0.004053743565806264
myocardial,0.004053743565806264
effusion,0.004053743565806264
lethargy,0.004053743565806264
toxic,0.004053743565806264
titers,0.004053743565806264
scleroderma,0.004053743565806264
excessive,0.004053743565806264
thoracic,0.004053743565806264
73m2,0.004053743565806264
alemtuzumab,0.004053743565806264
intent,0.004053743565806264
goal,0.004053743565806264
involves,0.004053743565806264
local,0.004053743565806264
5ml,0.004053743565806264
glaucoma,0.004053743565806264
screened,0.004053743565806264
prophylactic,0.004053743565806264
rest,0.004053743565806264
project,0.004053743565806264
called,0.004053743565806264
withdrawn,0.004053743565806264
reason,0.004053743565806264
stop,0.004053743565806264
suffering,0.004053743565806264
reappearance,0.004053743565806264
father,0.004053743565806264
healthcare,0.004053743565806264
365,0.004053743565806264
immunophenotyping,0.004053743565806264
successive,0.004053743565806264
oesogastric,0.004053743565806264
assessing,0.004053743565806264
ileum,0.004053743565806264
failures,0.004053743565806264
complication,0.004053743565806264
accounting,0.004053743565806264
takes,0.004053743565806264
rarely,0.004053743565806264
haematological,0.004053743565806264
bolus,0.004053743565806264
practitioner,0.004053743565806264
applicable,0.004053743565806264
neoplasia,0.004053743565806264
coli,0.004053743565806264
randomisation,0.004053743565806264
smpc,0.004053743565806264
cytogenetic,0.004053743565806264
lymphoid,0.004053743565806264
cy,0.004053743565806264
infiltrate,0.004053743565806264
showing,0.004053743565806264
swab,0.004053743565806264
diameter,0.004053743565806264
commonly,0.004053743565806264
immunology,0.004053743565806264
hematologic,0.004053743565806264
dyslipidemia,0.004053743565806264
stock,0.004053743565806264
suggestive,0.004053743565806264
understand,0.004053743565806264
sufficient,0.004053743565806264
fact,0.003932644041126101
act,0.003932644041126101
stroke,0.003932644041126101
deterioration,0.003932644041126101
complementary,0.003932644041126101
depression,0.003932644041126101
version,0.003932644041126101
recorded,0.003932644041126101
flare,0.003932644041126101
define,0.003932644041126101
taking,0.003932644041126101
provided,0.003932644041126101
beta,0.003932644041126101
responsible,0.003932644041126101
causes,0.003932644041126101
require,0.003932644041126101
gamma,0.003932644041126101
consumption,0.003932644041126101
examination,0.003932644041126101
binding,0.003932644041126101
pathology,0.003932644041126101
scores,0.003932644041126101
formula,0.003932644041126101
regression,0.003932644041126101
activation,0.003932644041126101
determined,0.003932644041126101
bleeding,0.003932644041126101
chosen,0.003932644041126101
usually,0.003932644041126101
relative,0.003932644041126101
validated,0.0037532140235310195
questionnaires,0.0035542396493709327
tests,0.0035542396493709327
cross,0.0035542396493709327
murine,0.0035542396493709327
functional,0.0035542396493709327
efficient,0.0035542396493709327
times,0.0035542396493709327
61,0.0035542396493709327
corresponding,0.0035542396493709327
circulating,0.0035542396493709327
rheumatoid,0.0035542396493709327
consider,0.0035542396493709327
gold,0.0035542396493709327
chorioretinal,0.0035542396493709327
newly,0.0035542396493709327
requirements,0.0035542396493709327
validate,0.0035542396493709327
sequential,0.0035542396493709327
plasmapheresis,0.0035542396493709327
frequently,0.0035542396493709327
radiotherapy,0.0035542396493709327
fludrocortisone,0.0035542396493709327
approximately,0.0035542396493709327
recurrence,0.0035542396493709327
spontaneous,0.0035542396493709327
missing,0.0035542396493709327
half,0.0035542396493709327
adherence,0.0035542396493709327
independence,0.0035542396493709327
conclusion,0.0035542396493709327
bilag,0.0035542396493709327
exploratory,0.0035542396493709327
outpatient,0.0035542396493709327
informative,0.0035542396493709327
infiltration,0.0035542396493709327
relationship,0.0035542396493709327
extensive,0.0035542396493709327
authorized,0.0035542396493709327
authorization,0.0035542396493709327
maintenance,0.0035542396493709327
avoid,0.0035542396493709327
prescription,0.0035542396493709327
detection,0.0035542396493709327
immunosuppressant,0.0035542396493709327
diagnostic,0.0035542396493709327
minimum,0.0035542396493709327
assay,0.0035542396493709327
complement,0.0035542396493709327
chelation,0.0035542396493709327
ferritin,0.0035542396493709327
hydrocortisone,0.0035542396493709327
eradication,0.0035542396493709327
enroll,0.0035542396493709327
volume,0.0035542396493709327
enzymes,0.0035542396493709327
131,0.0035232870872648485
run,0.0035232870872648485
warranted,0.0035232870872648485
zhang,0.0035232870872648485
lacking,0.0035232870872648485
105,0.0035232870872648485
phd,0.0035232870872648485
yellow,0.0035232870872648485
benlysta,0.0035232870872648485
paracetamol,0.0035232870872648485
retrospectively,0.0035232870872648485
jh,0.0035232870872648485
leukoencephalopathy,0.0035232870872648485
leukemic,0.0035232870872648485
les,0.0035232870872648485
council,0.0035232870872648485
progressing,0.0035232870872648485
neurologic,0.0035232870872648485
presentation,0.0035232870872648485
underwent,0.0035232870872648485
unblinding,0.0035232870872648485
universite,0.0035232870872648485
expecting,0.0035232870872648485
hypotension,0.0035232870872648485
hormone,0.0035232870872648485
sud,0.0035232870872648485
dysmetabolic,0.0035232870872648485
designed,0.0035232870872648485
competent,0.0035232870872648485
comparisons,0.0035232870872648485
ifn,0.0035232870872648485
subset,0.0035232870872648485
hypothyroidism,0.0035232870872648485
nephritis,0.0035232870872648485
generally,0.0035232870872648485
gave,0.0035232870872648485
gained,0.0035232870872648485
correspondence,0.0035232870872648485
limiting,0.0035232870872648485
consisting,0.0035232870872648485
cb,0.0035232870872648485
variations,0.0035232870872648485
edta,0.0035232870872648485
filiere,0.0035232870872648485
figure,0.0035232870872648485
biologically,0.0035232870872648485
2mg,0.0035232870872648485
preliminary,0.0035232870872648485
demets,0.0035232870872648485
adding,0.0035232870872648485
universal,0.0035232870872648485
délégation,0.0035232870872648485
proved,0.0035232870872648485
transcripts,0.0035232870872648485
proportional,0.0035232870872648485
ethics,0.0035232870872648485
valuable,0.0035232870872648485
plays,0.0035232870872648485
appearance,0.0035232870872648485
appear,0.0035232870872648485
binders,0.0035232870872648485
ulcers,0.0035232870872648485
ulcerations,0.0035232870872648485
starch,0.0035232870872648485
immunosuppressed,0.0035232870872648485
departments,0.0035232870872648485
extensively,0.0035232870872648485
324,0.0035232870872648485
heterogeneity,0.0035232870872648485
fistula,0.0035232870872648485
ipss,0.0035232870872648485
intravitreal,0.0035232870872648485
septic,0.0035232870872648485
cox,0.0035232870872648485
intramuscular,0.0035232870872648485
aom,0.0035232870872648485
liquid,0.0035232870872648485
osseous,0.0035232870872648485
vaginal,0.0035232870872648485
v5,0.0035232870872648485
decade,0.0035232870872648485
staff,0.0035232870872648485
refraining,0.0035232870872648485
referral,0.0035232870872648485
mechanisms,0.0035232870872648485
mathec,0.0035232870872648485
dexamethasone,0.0035232870872648485
developing,0.0035232870872648485
exceed,0.0035232870872648485
rescue,0.0035232870872648485
sfgm,0.0035232870872648485
interstitial,0.0035232870872648485
represent,0.0035232870872648485
consist,0.0035232870872648485
nicolas,0.0035232870872648485
bio,0.0035232870872648485
thoroughly,0.0035232870872648485
hb,0.0035232870872648485
mll,0.0035232870872648485
concept,0.0035232870872648485
registration,0.0035232870872648485
sponsors,0.0035232870872648485
cytotoxicity,0.0035232870872648485
cytopathogenic,0.0035232870872648485
improvements,0.0035232870872648485
immunes,0.0035232870872648485
gvl,0.0035232870872648485
explained,0.0035232870872648485
precludes,0.0035232870872648485
preclude,0.0035232870872648485
argenteuil,0.0035232870872648485
archiving,0.0035232870872648485
spectrum,0.0035232870872648485
nowadays,0.0035232870872648485
systematically,0.0035232870872648485
hbsag,0.0035232870872648485
mutations,0.0035232870872648485
cmu,0.0035232870872648485
consented,0.0035232870872648485
alcohol,0.0035232870872648485
ago,0.0035232870872648485
aggressive,0.0035232870872648485
disappointing,0.0035232870872648485
directed,0.0035232870872648485
terminal,0.0035232870872648485
techniques,0.0035232870872648485
individualized,0.0035232870872648485
relevant,0.0035232870872648485
relapsed,0.0035232870872648485
manner,0.0035232870872648485
urgent,0.0035232870872648485
unwillingness,0.0035232870872648485
untreated,0.0035232870872648485
authors,0.0035232870872648485
hazard,0.0035232870872648485
handle,0.0035232870872648485
tc,0.0035232870872648485
98,0.0035232870872648485
crucial,0.0035232870872648485
advantage,0.0035232870872648485
industrial,0.0035232870872648485
confidence,0.0035232870872648485
remaining,0.0035232870872648485
remained,0.0035232870872648485
soluble,0.0035232870872648485
induce,0.0035232870872648485
multifocal,0.0035232870872648485
foam,0.0035232870872648485
inserm,0.0035232870872648485
innovative,0.0035232870872648485
innovation,0.0035232870872648485
approval,0.0035232870872648485
bortezomib,0.0035232870872648485
gut,0.0035232870872648485
guidance,0.0035232870872648485
groupe,0.0035232870872648485
gray,0.0035232870872648485
azoospermia,0.0035232870872648485
molecules,0.0035232870872648485
modifying,0.0035232870872648485
expansion,0.0035232870872648485
exists,0.0035232870872648485
exhaustive,0.0035232870872648485
uveitic,0.0035232870872648485
potassium,0.0035232870872648485
osteoporosis,0.0035232870872648485
lymphopenia,0.0035232870872648485
ring,0.0035232870872648485
contraindications,0.0035232870872648485
le,0.0035232870872648485
placebos,0.0035232870872648485
1st,0.0035232870872648485
estrogen,0.0035232870872648485
62,0.0035232870872648485
58,0.0035232870872648485
toulouse,0.0035232870872648485
furthermore,0.0035232870872648485
proteins,0.0035232870872648485
lan,0.0035232870872648485
roughly,0.0035232870872648485
111,0.0035232870872648485
enhance,0.0035232870872648485
146,0.0035232870872648485
concomitant,0.0035013136943527036
starting,0.0035013136943527036
taken,0.0035013136943527036
loss,0.0035013136943527036
appropriate,0.0035013136943527036
specified,0.0035013136943527036
participant,0.00314611523290088
identification,0.00314611523290088
http,0.00314611523290088
beginning,0.00314611523290088
www,0.00314611523290088
stay,0.00314611523290088
documented,0.00314611523290088
models,0.00314611523290088
continue,0.00314611523290088
infarct,0.00314611523290088
set,0.00314611523290088
table,0.00314611523290088
choice,0.00314611523290088
sledai,0.00314611523290088
silent,0.00314611523290088
malignant,0.00314611523290088
functions,0.00314611523290088
selena,0.00314611523290088
authority,0.00314611523290088
1500,0.003040307674354698
versions,0.003040307674354698
phenotypes,0.003040307674354698
web,0.003040307674354698
escalation,0.003040307674354698
2000,0.003040307674354698
applies,0.003040307674354698
repair,0.003040307674354698
maintained,0.003040307674354698
background,0.003040307674354698
collaboration,0.003040307674354698
existing,0.003040307674354698
flu,0.003040307674354698
archived,0.003040307674354698
marginal,0.003040307674354698
ctae,0.003040307674354698
crt,0.003040307674354698
fluorescein,0.003040307674354698
reliability,0.003040307674354698
confounders,0.003040307674354698
majority,0.003040307674354698
critical,0.003040307674354698
noted,0.003040307674354698
noninfectious,0.003040307674354698
fleming,0.003040307674354698
explore,0.003040307674354698
culture,0.003040307674354698
inhibitors,0.003040307674354698
ctfg,0.003040307674354698
crohns,0.003040307674354698
cytopenia,0.003040307674354698
spending,0.003040307674354698
deep,0.003040307674354698
decisions,0.003040307674354698
75,0.003040307674354698
abdominal,0.003040307674354698
spot,0.003040307674354698
masquerade,0.003040307674354698
inefficacy,0.003040307674354698
conversely,0.003040307674354698
66,0.003040307674354698
larger,0.003040307674354698
kinase,0.003040307674354698
latent,0.003040307674354698
futility,0.003040307674354698
lariboisiere,0.003040307674354698
mdrd,0.003040307674354698
actual,0.003040307674354698
diaphragm,0.003040307674354698
hemagglutinins,0.003040307674354698
populations,0.003040307674354698
exam,0.003040307674354698
reports,0.003040307674354698
policy,0.003040307674354698
segments,0.003040307674354698
courses,0.003040307674354698
findings,0.003040307674354698
finally,0.003040307674354698
aplasia,0.003040307674354698
intraocular,0.003040307674354698
register,0.003040307674354698
ss,0.003040307674354698
apparition,0.003040307674354698
dropping,0.003040307674354698
van,0.003040307674354698
pleural,0.003040307674354698
framework,0.003040307674354698
natural,0.003040307674354698
protocols,0.003040307674354698
components,0.003040307674354698
ileocolonoscopy,0.003040307674354698
oncolytic,0.003040307674354698
obrien,0.003040307674354698
process,0.003040307674354698
reactivations,0.003040307674354698
started,0.003040307674354698
resection,0.003040307674354698
respect,0.003040307674354698
lineage,0.003040307674354698
clin,0.003040307674354698
gives,0.003040307674354698
film,0.003040307674354698
accepted,0.003040307674354698
accompanied,0.003040307674354698
nerve,0.003040307674354698
n1,0.003040307674354698
checked,0.003040307674354698
igg,0.003040307674354698
compatible,0.003040307674354698
igra,0.003040307674354698
detecting,0.003040307674354698
med,0.003040307674354698
successfully,0.003040307674354698
tyrosine,0.003040307674354698
blockade,0.003040307674354698
studied,0.003040307674354698
fecal,0.003040307674354698
fewer,0.003040307674354698
neuro,0.003040307674354698
projected,0.003040307674354698
undergo,0.003040307674354698
suggested,0.003040307674354698
scheme,0.003040307674354698
joints,0.003040307674354698
cardiovascular,0.003040307674354698
001,0.003040307674354698
1000,0.003040307674354698
03,0.003040307674354698
zone,0.003040307674354698
entire,0.003040307674354698
follows,0.0028010509554821624
notably,0.0028010509554821624
uninjected,0.0028010509554821624
radiation,0.0028010509554821624
ensure,0.0028010509554821624
mixed,0.0028010509554821624
family,0.0028010509554821624
profiles,0.0026656797370281995
responding,0.0026656797370281995
tubes,0.0026656797370281995
fixed,0.0026656797370281995
drop,0.0026656797370281995
necrosis,0.0026656797370281995
beneficial,0.0026656797370281995
nephropathy,0.0026656797370281995
gammaglobulin,0.0026656797370281995
transmission,0.0026656797370281995
documentation,0.0026656797370281995
glucocorticoids,0.0026656797370281995
c4,0.0026656797370281995
controls,0.0026656797370281995
vasopressors,0.0026656797370281995
provisional,0.0026656797370281995
proportions,0.0026656797370281995
base,0.0026656797370281995
monotherapy,0.0026656797370281995
microalbuminuria,0.0026656797370281995
mononuclear,0.0026656797370281995
details,0.0026656797370281995
determination,0.0026656797370281995
survey,0.0026656797370281995
borr,0.0026656797370281995
sri,0.0026656797370281995
longer,0.0026656797370281995
anxiety,0.0026656797370281995
atrial,0.0026656797370281995
phenotyping,0.0026656797370281995
deaths,0.0026656797370281995
osteonecrosis,0.0026656797370281995
v3,0.0026656797370281995
ctc,0.0026656797370281995
applied,0.0026656797370281995
initiated,0.0026656797370281995
mass,0.0026656797370281995
admission,0.0026656797370281995
oxygen,0.0026656797370281995
reporting,0.0026656797370281995
intolerance,0.0026656797370281995
estimation,0.0026656797370281995
epidemiology,0.0026656797370281995
world,0.0026656797370281995
whichever,0.0026656797370281995
implemented,0.00235958642467566
immediate,0.00235958642467566
fully,0.00235958642467566
mechanical,0.00235958642467566
collect,0.00235958642467566
ventilation,0.00235958642467566
note,0.00235958642467566
phenotypic,0.00235958642467566
unacceptable,0.00235958642467566
reasons,0.00235958642467566
immunogenicity,0.00235958642467566
attributed,0.00235958642467566
correlated,0.00235958642467566
respond,0.00235958642467566
overlap,0.00235958642467566
virological,0.00235958642467566
indexed,0.00235958642467566
begin,0.0023488580581765657
dyspnea,0.0023488580581765657
dysfunctions,0.0023488580581765657
unite,0.0023488580581765657
ligands,0.0023488580581765657
colchicine,0.0023488580581765657
leucocytes,0.0023488580581765657
colitis,0.0023488580581765657
cognitive,0.0023488580581765657
colloidal,0.0023488580581765657
mmr,0.0023488580581765657
display,0.0023488580581765657
diverticulitis,0.0023488580581765657
amenable,0.0023488580581765657
coordinator,0.0023488580581765657
cooperation,0.0023488580581765657
dividing,0.0023488580581765657
therapie,0.0023488580581765657
pten,0.0023488580581765657
montpellier,0.0023488580581765657
morphologic,0.0023488580581765657
mrd1,0.0023488580581765657
qualitative,0.0023488580581765657
glutamic,0.0023488580581765657
glutamopyruvatetransferase,0.0023488580581765657
5n,0.0023488580581765657
unknown,0.0023488580581765657
psychiatry,0.0023488580581765657
balance,0.0023488580581765657
clones,0.0023488580581765657
cluster,0.0023488580581765657
expertise,0.0023488580581765657
governing,0.0023488580581765657
73,0.0023488580581765657
monocular,0.0023488580581765657
2g,0.0023488580581765657
600mg,0.0023488580581765657
molecule,0.0023488580581765657
randomize,0.0023488580581765657
axis,0.0023488580581765657
bacillus,0.0023488580581765657
8g,0.0023488580581765657
survive,0.0023488580581765657
microcrystalline,0.0023488580581765657
microenvironment,0.0023488580581765657
microsatellite,0.0023488580581765657
reaching,0.0023488580581765657
justified,0.0023488580581765657
assumption,0.0023488580581765657
accurate,0.0023488580581765657
henri,0.0023488580581765657
herpetic,0.0023488580581765657
hg,0.0023488580581765657
histologically,0.0023488580581765657
hazards,0.0023488580581765657
83,0.0023488580581765657
84,0.0023488580581765657
ras,0.0023488580581765657
associations,0.0023488580581765657
guarantees,0.0023488580581765657
guided,0.0023488580581765657
tcr,0.0023488580581765657
h1,0.0023488580581765657
h2,0.0023488580581765657
hand,0.0023488580581765657
uropathogen,0.0023488580581765657
ustekinumab,0.0023488580581765657
office,0.0023488580581765657
cfu,0.0023488580581765657
modulation,0.0023488580581765657
challenge,0.0023488580581765657
2nd,0.0023488580581765657
344,0.0023488580581765657
false,0.0023488580581765657
autoreactive,0.0023488580581765657
auxiliary,0.0023488580581765657
hbcab,0.0023488580581765657
dioxide,0.0023488580581765657
systolic,0.0023488580581765657
suppression,0.0023488580581765657
mobilization,0.0023488580581765657
chain,0.0023488580581765657
kind,0.0023488580581765657
endocrinal,0.0023488580581765657
enhances,0.0023488580581765657
10mm,0.0023488580581765657
110,0.0023488580581765657
130,0.0023488580581765657
washout,0.0023488580581765657
zhou,0.0023488580581765657
pathways,0.0023488580581765657
cancerologie,0.0023488580581765657
intraveinously,0.0023488580581765657
nonsteroidal,0.0023488580581765657
notch1,0.0023488580581765657
novel,0.0023488580581765657
transfusional,0.0023488580581765657
francois,0.0023488580581765657
tribeca,0.0023488580581765657
undergone,0.0023488580581765657
unemployment,0.0023488580581765657
pressures,0.0023488580581765657
principle,0.0023488580581765657
nuclear,0.0023488580581765657
producing,0.0023488580581765657
vitiligo,0.0023488580581765657
anhydrous,0.0023488580581765657
100mg,0.0023488580581765657
104,0.0023488580581765657
worldwide,0.0023488580581765657
ya,0.0023488580581765657
patterns,0.0023488580581765657
pellets,0.0023488580581765657
percentages,0.0023488580581765657
percutaneous,0.0023488580581765657
largest,0.0023488580581765657
burden,0.0023488580581765657
patch,0.0023488580581765657
catheterization,0.0023488580581765657
petersen,0.0023488580581765657
categorical,0.0023488580581765657
2007,0.0023488580581765657
coronary,0.0023488580581765657
sale,0.0023488580581765657
amylase,0.0023488580581765657
antiinflammatory,0.0023488580581765657
rondelli,0.0023488580581765657
162mg,0.0023488580581765657
psoriasis,0.0023488580581765657
thymoglobuline,0.0023488580581765657
thyroxine,0.0023488580581765657
titanium,0.0023488580581765657
cni,0.0023488580581765657
mydriasis,0.0023488580581765657
bdca,0.0023488580581765657
7g,0.0023488580581765657
disodium,0.0023488580581765657
bladder,0.0023488580581765657
biocollection,0.0023488580581765657
blockers,0.0023488580581765657
blocking,0.0023488580581765657
characteristic,0.0023488580581765657
carriage,0.0023488580581765657
carry,0.0023488580581765657
physiologic,0.0023488580581765657
vedolizumab,0.0023488580581765657
urgently,0.0023488580581765657
contrasting,0.0023488580581765657
leaving,0.0023488580581765657
rhythm,0.0023488580581765657
blast,0.0023488580581765657
3n,0.0023488580581765657
3rd,0.0023488580581765657
finding,0.0023488580581765657
375,0.0023488580581765657
chi,0.0023488580581765657
46,0.0023488580581765657
city,0.0023488580581765657
behaviour,0.0023488580581765657
51,0.0023488580581765657
57,0.0023488580581765657
gammaglobulines,0.0023488580581765657
necessitating,0.0023488580581765657
programs,0.0023488580581765657
propensity,0.0023488580581765657
fbxw7,0.0023488580581765657
feature,0.0023488580581765657
gastric,0.0023488580581765657
generated,0.0023488580581765657
genes,0.0023488580581765657
geno,0.0023488580581765657
genova,0.0023488580581765657
myelodysplasia,0.0023488580581765657
nc,0.0023488580581765657
network,0.0023488580581765657
confirming,0.0023488580581765657
congestive,0.0023488580581765657
adrenal,0.0023488580581765657
vena,0.0023488580581765657
1h,0.0023488580581765657
picomolar,0.0023488580581765657
pituitary,0.0023488580581765657
packed,0.0023488580581765657
painful,0.0023488580581765657
panuveitis,0.0023488580581765657
competing,0.0023488580581765657
variability,0.0023488580581765657
silica,0.0023488580581765657
simultaneous,0.0023488580581765657
lyon,0.0023488580581765657
lytic,0.0023488580581765657
macrophages,0.0023488580581765657
intolerant,0.0023488580581765657
court,0.0023488580581765657
covariate,0.0023488580581765657
sequence,0.0023488580581765657
plasmatic,0.0023488580581765657
curves,0.0023488580581765657
cutanee,0.0023488580581765657
advocated,0.0023488580581765657
influence,0.0023488580581765657
inherited,0.0023488580581765657
cryostem,0.0023488580581765657
specificity,0.0023488580581765657
arrhythmia,0.0023488580581765657
articles,0.0023488580581765657
articular,0.0023488580581765657
removes,0.0023488580581765657
sjogrens,0.0023488580581765657
sm,0.0023488580581765657
institutions,0.0023488580581765657
insulin,0.0023488580581765657
signal,0.0023488580581765657
signals,0.0023488580581765657
algorithm,0.0023488580581765657
alkylating,0.0023488580581765657
intensification,0.0023488580581765657
reliable,0.0023488580581765657
removal,0.0023488580581765657
situations,0.0023488580581765657
contraceptives,0.0023488580581765657
water,0.0023488580581765657
chromosome,0.0023488580581765657
formal,0.0023488580581765657
formulation,0.0023488580581765657
tube,0.0023488580581765657
favourable,0.0023488580581765657
produced,0.0023488580581765657
ligation,0.0023488580581765657
ja,0.0023488580581765657
amplified,0.0023488580581765657
jean,0.0023488580581765657
novo,0.0023488580581765657
professor,0.0023488580581765657
doubled,0.0023488580581765657
driven,0.0023488580581765657
waiting,0.0023488580581765657
140,0.0023488580581765657
2004,0.0023488580581765657
catheter,0.0023488580581765657
chloride,0.0023488580581765657
chlorambucil,0.0023488580581765657
jak,0.0023488580581765657
seen,0.0023488580581765657
intensified,0.0023488580581765657
crocchiolo,0.0023488580581765657
conjunction,0.0023488580581765657
service,0.0023488580581765657
interactions,0.0023488580581765657
intermittent,0.0023488580581765657
interquartile,0.0023488580581765657
investigation,0.0023488580581765657
investigations,0.0023488580581765657
contra,0.0023488580581765657
selecting,0.0023488580581765657
separated,0.0023488580581765657
consists,0.0023488580581765657
leflunomide,0.0023488580581765657
ischemic,0.0023488580581765657
isohemagglutinins,0.0023488580581765657
itac,0.0023488580581765657
kinetic,0.0023488580581765657
kt,0.0023488580581765657
scanner,0.0023488580581765657
revised,0.0023488580581765657
irradiated,0.0023488580581765657
predicted,0.0023488580581765657
predictive,0.0023488580581765657
rectal,0.0023488580581765657
rectum,0.0023488580581765657
add,0.0023488580581765657
depend,0.0023488580581765657
sterility,0.0023488580581765657
immunity,0.0023488580581765657
immunoglobulin,0.0023488580581765657
recognition,0.0023488580581765657
induces,0.0023488580581765657
mellitus,0.0023488580581765657
merkel,0.0023488580581765657
metabolizing,0.0023488580581765657
metastases,0.0023488580581765657
depends,0.0023488580581765657
mcc,0.0023488580581765657
meaningful,0.0023488580581765657
measurable,0.0023488580581765657
immunosuppressors,0.0023488580581765657
impairment,0.0023488580581765657
recombinant,0.0023488580581765657
suicidal,0.0023488580581765657
suicide,0.0023488580581765657
superficial,0.0023488580581765657
mfi,0.0023488580581765657
compartments,0.0023488580581765657
realization,0.0023488580581765657
successively,0.0023488580581765657
hospitals,0.0023488580581765657
hydrochloride,0.0023488580581765657
hydroxyomeprazole,0.0023488580581765657
cellulose,0.0023488580581765657
subsets,0.0023488580581765657
substrate,0.0023488580581765657
icbd,0.0023488580581765657
225,0.0023488580581765657
excised,0.0023488580581765657
echocardiographies,0.0023488580581765657
boundaries,0.0023488580581765657
ophthalmologic,0.0023488580581765657
ophthalmological,0.0023488580581765657
opportunistic,0.0023488580581765657
cedex,0.0023488580581765657
hypromellose,0.0023488580581765657
exceptions,0.0023488580581765657
exchanges,0.0023488580581765657
positivity,0.0023488580581765657
possibility,0.0023488580581765657
organization,0.0023488580581765657
origin,0.0023488580581765657
potency,0.0023488580581765657
v2,0.0023488580581765657
indicate,0.0023488580581765657
cyp3a4,0.0023488580581765657
implants,0.0023488580581765657
sofa,0.0023488580581765657
addressed,0.0023488580581765657
etanercept,0.0023488580581765657
vary,0.0023488580581765657
brain,0.0023488580581765657
bregante,0.0023488580581765657
cava,0.0023488580581765657
oxaloacetictransferase,0.0023488580581765657
bsas,0.0023488580581765657
polymerase,0.0023488580581765657
evasion,0.0023488580581765657
cytolysis,0.0023488580581765657
secreted,0.0023488580581765657
aid,0.0023488580581765657
lipase,0.0023488580581765657
locally,0.0023488580581765657
jelly,0.0023488580581765657
jm,0.0023488580581765657
john,0.0023488580581765657
jp,0.0023488580581765657
judgement,0.0023488580581765657
erythropoietin,0.0023488580581765657
increases,0.0023488580581765657
pao2,0.0023488580581765657
iga,0.0023488580581765657
ikzf1,0.0023488580581765657
il6,0.0023488580581765657
complex,0.0023488580581765657
comprehensive,0.0023488580581765657
computation,0.0023488580581765657
concluded,0.0023488580581765657
regurgitation,0.0023488580581765657
adherent,0.0023488580581765657
improves,0.0023488580581765657
california,0.0023488580581765657
principal,0.002100788216611622
interaction,0.002100788216611622
points,0.002100788216611622
opinion,0.002100788216611622
collected,0.002100788216611622
thrombosis,0.002100788216611622
cardio,0.002026871782903132
cap,0.002026871782903132
typing,0.002026871782903132
ulceration,0.002026871782903132
true,0.002026871782903132
neoplasm,0.002026871782903132
38c,0.002026871782903132
trv,0.002026871782903132
36v2,0.002026871782903132
file,0.002026871782903132
occlusive,0.002026871782903132
website,0.002026871782903132
enhancement,0.002026871782903132
vod,0.002026871782903132
epi,0.002026871782903132
way,0.002026871782903132
tricuspid,0.002026871782903132
unaffected,0.002026871782903132
unconsciousness,0.002026871782903132
observation,0.002026871782903132
3mg,0.002026871782903132
gadolinium,0.002026871782903132
ulcerated,0.002026871782903132
treating,0.002026871782903132
negativation,0.002026871782903132
ckd,0.002026871782903132
proposes,0.002026871782903132
glucocorticoid,0.002026871782903132
nature,0.002026871782903132
dry,0.002026871782903132
properly,0.002026871782903132
transfused,0.002026871782903132
7mg,0.002026871782903132
blocks,0.002026871782903132
cm,0.002026871782903132
gonadic,0.002026871782903132
pulse,0.002026871782903132
telephone,0.002026871782903132
monocytes,0.002026871782903132
thanks,0.002026871782903132
disappearance,0.002026871782903132
disability,0.002026871782903132
graall2003,0.002026871782903132
experts,0.002026871782903132
familial,0.002026871782903132
external,0.002026871782903132
functioning,0.002026871782903132
neutrophiles,0.002026871782903132
useful,0.002026871782903132
gt,0.002026871782903132
mn,0.002026871782903132
randomly,0.002026871782903132
combine,0.002026871782903132
haplotype,0.002026871782903132
accrual,0.002026871782903132
switzerland,0.002026871782903132
microg,0.002026871782903132
surveillance,0.002026871782903132
hope,0.002026871782903132
attacks,0.002026871782903132
edge,0.002026871782903132
expect,0.002026871782903132
identifying,0.002026871782903132
depressive,0.002026871782903132
study,0.002026871782903132
meier,0.002026871782903132
immunologic,0.002026871782903132
aspiration,0.002026871782903132
sperm,0.002026871782903132
immediately,0.002026871782903132
stabilization,0.002026871782903132
regional,0.002026871782903132
standards,0.002026871782903132
immunomodulation,0.002026871782903132
v1,0.002026871782903132
bn,0.002026871782903132
org,0.002026871782903132
optional,0.002026871782903132
premedication,0.002026871782903132
proteasome,0.002026871782903132
example,0.002026871782903132
validity,0.002026871782903132
matching,0.002026871782903132
inactivity,0.002026871782903132
conclusions,0.002026871782903132
concentrations,0.002026871782903132
sponge,0.002026871782903132
adjusted,0.002026871782903132
cytometry,0.002026871782903132
implies,0.002026871782903132
budesonide,0.002026871782903132
brutal,0.002026871782903132
variables,0.002026871782903132
efficiency,0.002026871782903132
effectively,0.002026871782903132
concurrent,0.002026871782903132
sp02,0.002026871782903132
administrated,0.002026871782903132
lymphedema,0.002026871782903132
simple,0.002026871782903132
signing,0.002026871782903132
bowel,0.002026871782903132
pancytopenia,0.002026871782903132
pancreatitis,0.002026871782903132
velocity,0.002026871782903132
sharing,0.002026871782903132
interview,0.002026871782903132
sf36,0.002026871782903132
settings,0.002026871782903132
conseil,0.002026871782903132
lost,0.002026871782903132
relating,0.002026871782903132
cream,0.002026871782903132
intra,0.002026871782903132
ll03,0.002026871782903132
aimed,0.002026871782903132
shock,0.002026871782903132
sectional,0.002026871782903132
country,0.002026871782903132
appeared,0.002026871782903132
apparent,0.002026871782903132
encephalitis,0.002026871782903132
electrolytes,0.002026871782903132
phosphate,0.002026871782903132
150mg,0.002026871782903132
vfq,0.002026871782903132
verified,0.002026871782903132
ligand,0.002026871782903132
alterations,0.002026871782903132
karyotype,0.002026871782903132
kaplan,0.002026871782903132
controlling,0.002026871782903132
schemes,0.002026871782903132
ancillary,0.002026871782903132
angio,0.002026871782903132
correlate,0.002026871782903132
routine,0.002026871782903132
analyzing,0.002026871782903132
analyse,0.002026871782903132
saliva,0.002026871782903132
2006,0.002026871782903132
caecum,0.002026871782903132
bvas,0.002026871782903132
persistence,0.002026871782903132
amplification,0.0018766070117655098
includes,0.0018766070117655098
decision,0.0018766070117655098
ongoing,0.0018766070117655098
paraclinical,0.0017771198246854664
ensuring,0.0017771198246854664
haut,0.0017771198246854664
acr,0.0017771198246854664
decided,0.0017771198246854664
distribution,0.0017771198246854664
graaph,0.0017771198246854664
special,0.0017771198246854664
degree,0.0017771198246854664
frozen,0.0017771198246854664
software,0.0017771198246854664
similarly,0.0017771198246854664
sign,0.0017771198246854664
air,0.0017771198246854664
surgical,0.0017771198246854664
agreed,0.0017771198246854664
intervals,0.0017771198246854664
serological,0.0017771198246854664
pharmacodynamics,0.0017771198246854664
creatininuria,0.0017771198246854664
alkaline,0.0017771198246854664
doppler,0.0017771198246854664
scheduled,0.0017771198246854664
saes,0.0017771198246854664
analyze,0.0017771198246854664
room,0.0017771198246854664
contact,0.0017771198246854664
logmar,0.0017771198246854664
load,0.0017771198246854664
continuous,0.0017771198246854664
hsv,0.0017771198246854664
phosphatase,0.0017771198246854664
enrollment,0.0017771198246854664
conduct,0.0017771198246854664
maintain,0.0017771198246854664
conjugate,0.0017771198246854664
recruited,0.0017771198246854664
compliance,0.0017771198246854664
marker,0.0017771198246854664
assigned,0.0017771198246854664
medullar,0.0017771198246854664
comparative,0.0017771198246854664
updated,0.0017771198246854664
explored,0.0017771198246854664
reactants,0.0017771198246854664
250,0.0017771198246854664
match,0.0017771198246854664
quantification,0.0017771198246854664
ms,0.0017771198246854664
clinic,0.0017771198246854664
clinical,0.0017771198246854664
v4,0.0017771198246854664
binomial,0.0017771198246854664
chose,0.0017771198246854664
myocarditis,0.0017771198246854664
priapism,0.0017771198246854664
established,0.0017771198246854664
block,0.0017771198246854664
essential,0.0017771198246854664
eq5d,0.0017771198246854664
cd19,0.0017771198246854664
brochure,0.0017771198246854664
zero,0.0017771198246854664
gr,0.00157305761645044
answer,0.00157305761645044
santé,0.00157305761645044
analysed,0.00157305761645044
achieved,0.00157305761645044
mmol,0.00157305761645044
modification,0.00157305761645044
allograft,0.00157305761645044
area,0.00157305761645044
class,0.00157305761645044
fish,0.00157305761645044
occurring,0.00157305761645044
law,0.00157305761645044
judgment,0.00157305761645044
hgf,0.00157305761645044
concerning,0.0014005254777410812
plan,0.0014005254777410812
https,0.0014005254777410812
investigators,0.0014005254777410812
flow,0.0014005254777410812
interfering,0.0011744290290882828
interestingly,0.0011744290290882828
verbal,0.0011744290290882828
sexually,0.0011744290290882828
verification,0.0011744290290882828
sex,0.0011744290290882828
agreeing,0.0011744290290882828
views,0.0011744290290882828
sf36v2,0.0011744290290882828
vigorous,0.0011744290290882828
interrogating,0.0011744290290882828
vii,0.0011744290290882828
donating,0.0011744290290882828
vi,0.0011744290290882828
donate,0.0011744290290882828
viii,0.0011744290290882828
sh,0.0011744290290882828
cps,0.0011744290290882828
covered,0.0011744290290882828
cover,0.0011744290290882828
creatininemia,0.0011744290290882828
creates,0.0011744290290882828
cr1,0.0011744290290882828
dopamine,0.0011744290290882828
couverture,0.0011744290290882828
cousin,0.0011744290290882828
couple,0.0011744290290882828
alloreactivity,0.0011744290290882828
fraumeni,0.0011744290290882828
phases,0.0011744290290882828
pfu,0.0011744290290882828
personalized,0.0011744290290882828
persistant,0.0011744290290882828
parasitic,0.0011744290290882828
doctor,0.0011744290290882828
parenterally,0.0011744290290882828
francais,0.0011744290290882828
fralle,0.0011744290290882828
treatment,0.0011744290290882828
transporters,0.0011744290290882828
transporter,0.0011744290290882828
allocation,0.0011744290290882828
administrative,0.0011744290290882828
singer,0.0011744290290882828
simultaneously,0.0011744290290882828
simplex,0.0011744290290882828
csi,0.0011744290290882828
cryoglobulinemic,0.0011744290290882828
cryoglobulin,0.0011744290290882828
infiltrating,0.0011744290290882828
cytochromes,0.0011744290290882828
fungals,0.0011744290290882828
fumarate,0.0011744290290882828
transport,0.0011744290290882828
cyp,0.0011744290290882828
cylinders,0.0011744290290882828
indicative,0.0011744290290882828
smoothing,0.0011744290290882828
smd,0.0011744290290882828
skins,0.0011744290290882828
sister,0.0011744290290882828
sinus,0.0011744290290882828
aesi,0.0011744290290882828
cut,0.0011744290290882828
inability,0.0011744290290882828
frequentist,0.0011744290290882828
catherization,0.0011744290290882828
cary,0.0011744290290882828
cystic,0.0011744290290882828
serologic,0.0011744290290882828
transplantations,0.0011744290290882828
cyclophophamide,0.0011744290290882828
agonists,0.0011744290290882828
affective,0.0011744290290882828
signatures,0.0011744290290882828
signature,0.0011744290290882828
intact,0.0011744290290882828
admissions,0.0011744290290882828
instructions,0.0011744290290882828
innate,0.0011744290290882828
injectables,0.0011744290290882828
ctla4,0.0011744290290882828
crospovidone,0.0011744290290882828
crisis,0.0011744290290882828
dated,0.0011744290290882828
adjudicated,0.0011744290290882828
infants,0.0011744290290882828
ineligible,0.0011744290290882828
indwelling,0.0011744290290882828
admitted,0.0011744290290882828
insult,0.0011744290290882828
language,0.0011744290290882828
lam,0.0011744290290882828
lactation,0.0011744290290882828
rr,0.0011744290290882828
routinely,0.0011744290290882828
roth,0.0011744290290882828
roster,0.0011744290290882828
ropinirole,0.0011744290290882828
roactemra,0.0011744290290882828
jy,0.0011744290290882828
fracture,0.0011744290290882828
costimulation,0.0011744290290882828
food,0.0011744290290882828
follicular,0.0011744290290882828
follicle,0.0011744290290882828
flutter,0.0011744290290882828
aneurysms,0.0011744290290882828
s0,0.0011744290290882828
ruxolitinib,0.0011744290290882828
lactating,0.0011744290290882828
laboratories,0.0011744290290882828
killed,0.0011744290290882828
correct,0.0011744290290882828
lbs,0.0011744290290882828
foster,0.0011744290290882828
leucocyte,0.0011744290290882828
fishers,0.0011744290290882828
fisher,0.0011744290290882828
fio2,0.0011744290290882828
umr,0.0011744290290882828
4000,0.0011744290290882828
anosmia,0.0011744290290882828
anomalies,0.0011744290290882828
animals,0.0011744290290882828
dramatic,0.0011744290290882828
draining,0.0011744290290882828
lasting,0.0011744290290882828
rise,0.0011744290290882828
antral,0.0011744290290882828
antivirals,0.0011744290290882828
antitumor,0.0011744290290882828
antimalarial,0.0011744290290882828
antiherpetic,0.0011744290290882828
antidepressants,0.0011744290290882828
richerand,0.0011744290290882828
rf,0.0011744290290882828
leclerc,0.0011744290290882828
anal,0.0011744290290882828
sat02,0.0011744290290882828
dqb1,0.0011744290290882828
correlations,0.0011744290290882828
sclicc,0.0011744290290882828
scl,0.0011744290290882828
schizophrenia,0.0011744290290882828
schedules,0.0011744290290882828
aneurysm,0.0011744290290882828
allergy,0.0011744290290882828
allele,0.0011744290290882828
septal,0.0011744290290882828
separate,0.0011744290290882828
senescence,0.0011744290290882828
jb,0.0011744290290882828
ionizing,0.0011744290290882828
interpretation,0.0011744290290882828
aminoside,0.0011744290290882828
amazzough,0.0011744290290882828
iterative,0.0011744290290882828
cotrimoxazole,0.0011744290290882828
imputable,0.0011744290290882828
tropical,0.0011744290290882828
4n,0.0011744290290882828
4ml,0.0011744290290882828
seven,0.0011744290290882828
setons,0.0011744290290882828
iqr,0.0011744290290882828
anas,0.0011744290290882828
join,0.0011744290290882828
johnson,0.0011744290290882828
involuntary,0.0011744290290882828
inv,0.0011744290290882828
salt,0.0011744290290882828
antibacterials,0.0011744290290882828
kdigo2012,0.0011744290290882828
kappa,0.0011744290290882828
doubling,0.0011744290290882828
ulcer,0.0011744290290882828
corticotrophin,0.0011744290290882828
turners,0.0011744290290882828
tumoral,0.0011744290290882828
tuberculin,0.0011744290290882828
4mg,0.0011744290290882828
470,0.0011744290290882828
450,0.0011744290290882828
40ml,0.0011744290290882828
triggered,0.0011744290290882828
tried,0.0011744290290882828
treg,0.0011744290290882828
frequencies,0.0011744290290882828
fluoropyrimidine,0.0011744290290882828
tutelle,0.0011744290290882828
dissection,0.0011744290290882828
displaying,0.0011744290290882828
7q,0.0011744290290882828
7ml,0.0011744290290882828
75017,0.0011744290290882828
75011,0.0011744290290882828
theorical,0.0011744290290882828
theophylline,0.0011744290290882828
thalassemias,0.0011744290290882828
suppository,0.0011744290290882828
supports,0.0011744290290882828
defective,0.0011744290290882828
summarized,0.0011744290290882828
h2o,0.0011744290290882828
t38c,0.0011744290290882828
t2,0.0011744290290882828
t1,0.0011744290290882828
syphilis,0.0011744290290882828
synechiae,0.0011744290290882828
symptothermal,0.0011744290290882828
sylvie,0.0011744290290882828
hdcy,0.0011744290290882828
dipropionate,0.0011744290290882828
diffusion,0.0011744290290882828
supervised,0.0011744290290882828
supra,0.0011744290290882828
suppressive,0.0011744290290882828
suppress,0.0011744290290882828
dme,0.0011744290290882828
dlqi,0.0011744290290882828
disturbances,0.0011744290290882828
hyperthermia,0.0011744290290882828
achievable,0.0011744290290882828
historically,0.0011744290290882828
histological,0.0011744290290882828
histidine,0.0011744290290882828
dibasic,0.0011744290290882828
distearate,0.0011744290290882828
absolue,0.0011744290290882828
abetimus,0.0011744290290882828
9th,0.0011744290290882828
susceptibility,0.0011744290290882828
survivals,0.0011744290290882828
surrogate,0.0011744290290882828
her2,0.0011744290290882828
hepatocyte,0.0011744290290882828
hemopathy,0.0011744290290882828
acetate,0.0011744290290882828
dialysis,0.0011744290290882828
distress,0.0011744290290882828
hbc,0.0011744290290882828
wcbp,0.0011744290290882828
engagement,0.0011744290290882828
engaged,0.0011744290290882828
endotype,0.0011744290290882828
endoscope,0.0011744290290882828
endocarditis,0.0011744290290882828
endocan,0.0011744290290882828
epilepsy,0.0011744290290882828
17q,0.0011744290290882828
188,0.0011744290290882828
granulocyte,0.0011744290290882828
difficile,0.0011744290290882828
96h,0.0011744290290882828
96,0.0011744290290882828
8mg,0.0011744290290882828
82,0.0011744290290882828
talc,0.0011744290290882828
paramedical,0.0011744290290882828
pap,0.0011744290290882828
paoli,0.0011744290290882828
phenylephrine,0.0011744290290882828
calprotectin,0.0011744290290882828
calmettes,0.0011744290290882828
tca,0.0011744290290882828
97,0.0011744290290882828
diet,0.0011744290290882828
surrogacy,0.0011744290290882828
sur,0.0011744290290882828
hematuria,0.0011744290290882828
gupta,0.0011744290290882828
guardian,0.0011744290290882828
107,0.0011744290290882828
12p,0.0011744290290882828
124,0.0011744290290882828
11q23,0.0011744290290882828
weighting,0.0011744290290882828
haplomudelederly,0.0011744290290882828
withdrawals,0.0011744290290882828
telomere,0.0011744290290882828
teleconsultation,0.0011744290290882828
technique,0.0011744290290882828
diseappearance,0.0011744290290882828
discussion,0.0011744290290882828
discovered,0.0011744290290882828
volunteers,0.0011744290290882828
patientsfiles,0.0011744290290882828
pathophysiology,0.0011744290290882828
pathologies,0.0011744290290882828
work,0.0011744290290882828
wittes,0.0011744290290882828
goldmann,0.0011744290290882828
impeding,0.0011744290290882828
spiegelhalter,0.0011744290290882828
spermicidal,0.0011744290290882828
specificities,0.0011744290290882828
specie,0.0011744290290882828
incarcerated,0.0011744290290882828
incapacity,0.0011744290290882828
60mmhg,0.0011744290290882828
5q,0.0011744290290882828
5mm,0.0011744290290882828
tm,0.0011744290290882828
dhtr,0.0011744290290882828
gm,0.0011744290290882828
glycolate,0.0011744290290882828
glycol,0.0011744290290882828
glycerol,0.0011744290290882828
staining,0.0011744290290882828
staggered,0.0011744290290882828
stability,0.0011744290290882828
srs2,0.0011744290290882828
square,0.0011744290290882828
spline,0.0011744290290882828
danlos,0.0011744290290882828
stents,0.0011744290290882828
tizanidine,0.0011744290290882828
dates,0.0011744290290882828
defining,0.0011744290290882828
levonorgestrel,0.0011744290290882828
defect,0.0011744290290882828
decisive,0.0011744290290882828
smp,0.0011744290290882828
cytomegalovirus,0.0011744290290882828
cytology,0.0011744290290882828
cytologic,0.0011744290290882828
cytogenetics,0.0011744290290882828
50mmhg,0.0011744290290882828
50g,0.0011744290290882828
implant,0.0011744290290882828
traditional,0.0011744290290882828
topoisomerase,0.0011744290290882828
tools,0.0011744290290882828
tonometry,0.0011744290290882828
cytoreductive,0.0011744290290882828
impressive,0.0011744290290882828
denotes,0.0011744290290882828
demonstration,0.0011744290290882828
deletion,0.0011744290290882828
additionally,0.0011744290290882828
acyclovir,0.0011744290290882828
impossible,0.0011744290290882828
4th,0.0011744290290882828
ideation,0.0011744290290882828
steroidal,0.0011744290290882828
acquisition,0.0011744290290882828
hyperacute,0.0011744290290882828
hrct,0.0011744290290882828
hour,0.0011744290290882828
sucrose,0.0011744290290882828
subtenons,0.0011744290290882828
substantial,0.0011744290290882828
hypoxia,0.0011744290290882828
descriptive,0.0011744290290882828
strips,0.0011744290290882828
stearyl,0.0011744290290882828
stool,0.0011744290290882828
stimulation,0.0011744290290882828
stimulating,0.0011744290290882828
ileitis,0.0011744290290882828
accrued,0.0011744290290882828
accessed,0.0011744290290882828
accelerate,0.0011744290290882828
designees,0.0011744290290882828
homeless,0.0011744290290882828
hold,0.0011744290290882828
hodgkins,0.0011744290290882828
diabetic,0.0011744290290882828
stress,0.0011744290290882828
stearate,0.0011744290290882828
imbalances,0.0011744290290882828
image,0.0011744290290882828
dependance,0.0011744290290882828
der,0.0011744290290882828
depleting,0.0011744290290882828
hypofertility,0.0011744290290882828
immunomonitoring,0.0011744290290882828
immunomodulator,0.0011744290290882828
impairing,0.0011744290290882828
impacts,0.0011744290290882828
ghsif,0.0011744290290882828
idec,0.0011744290290882828
6mg,0.0011744290290882828
ile,0.0011744290290882828
globulins,0.0011744290290882828
glass,0.0011744290290882828
gilz,0.0011744290290882828
timeframe,0.0011744290290882828
thymo,0.0011744290290882828
thrombopoietin,0.0011744290290882828
thrombocythemia,0.0011744290290882828
thirty,0.0011744290290882828
gobal,0.0011744290290882828
ihc,0.0011744290290882828
georges,0.0011744290290882828
ef,0.0011744290290882828
norepinephrine,0.0011744290290882828
nonparametric,0.0011744290290882828
nomegestrol,0.0011744290290882828
nodules,0.0011744290290882828
prof,0.0011744290290882828
bipolar,0.0011744290290882828
neoplasms,0.0011744290290882828
node,0.0011744290290882828
berry,0.0011744290290882828
beneficiary,0.0011744290290882828
retrieved,0.0011744290290882828
belgium,0.0011744290290882828
protected,0.0011744290290882828
prostatic,0.0011744290290882828
propylene,0.0011744290290882828
nineteen,0.0011744290290882828
nevous,0.0011744290290882828
bioactivity,0.0011744290290882828
bile,0.0011744290290882828
biggest,0.0011744290290882828
bg9588,0.0011744290290882828
profound,0.0011744290290882828
europa,0.0011744290290882828
belonging,0.0011744290290882828
biostatistics,0.0011744290290882828
biomarker,0.0011744290290882828
biochemical,0.0011744290290882828
proceed,0.0011744290290882828
obvious,0.0011744290290882828
obtention,0.0011744290290882828
chronology,0.0011744290290882828
prisoners,0.0011744290290882828
priority,0.0011744290290882828
prevents,0.0011744290290882828
prevalance,0.0011744290290882828
effort,0.0011744290290882828
veino,0.0011744290290882828
vein,0.0011744290290882828
vault,0.0011744290290882828
vasopressor,0.0011744290290882828
profiling,0.0011744290290882828
nsaids,0.0011744290290882828
notebook,0.0011744290290882828
circi,0.0011744290290882828
neck,0.0011744290290882828
property,0.0011744290290882828
promoted,0.0011744290290882828
proliferative,0.0011744290290882828
preservation,0.0011744290290882828
cirrhosis,0.0011744290290882828
circumstance,0.0011744290290882828
circumference,0.0011744290290882828
morality,0.0011744290290882828
pyuria,0.0011744290290882828
pursuant,0.0011744290290882828
pure,0.0011744290290882828
puncture,0.0011744290290882828
pumonary,0.0011744290290882828
pugnet,0.0011744290290882828
pt1,0.0011744290290882828
etonogestrel,0.0011744290290882828
psychological,0.0011744290290882828
monogamous,0.0011744290290882828
monobasic,0.0011744290290882828
quinolones,0.0011744290290882828
exception,0.0011744290290882828
excepted,0.0011744290290882828
excellent,0.0011744290290882828
quarterly,0.0011744290290882828
qualify,0.0011744290290882828
q3w,0.0011744290290882828
murin,0.0011744290290882828
edetate,0.0011744290290882828
psychosis,0.0011744290290882828
eta,0.0011744290290882828
estrogenic,0.0011744290290882828
valves,0.0011744290290882828
valued,0.0011744290290882828
validation,0.0011744290290882828
vaccination,0.0011744290290882828
excipient,0.0011744290290882828
proinflammatory,0.0011744290290882828
prohibit,0.0011744290290882828
neuroimaging,0.0011744290290882828
neurogenic,0.0011744290290882828
net,0.0011744290290882828
clairance,0.0011744290290882828
neoplastic,0.0011744290290882828
elaborate,0.0011744290290882828
clearly,0.0011744290290882828
muscles,0.0011744290290882828
bashey,0.0011744290290882828
barnich,0.0011744290290882828
balanced,0.0011744290290882828
psychiatrist,0.0011744290290882828
przepiorka,0.0011744290290882828
nct01795677,0.0011744290290882828
nasopharyngeal,0.0011744290290882828
needing,0.0011744290290882828
nephrostomy,0.0011744290290882828
overproduction,0.0011744290290882828
brother,0.0011744290290882828
broad,0.0011744290290882828
breakage,0.0011744290290882828
brca,0.0011744290290882828
carcinomas,0.0011744290290882828
capture,0.0011744290290882828
capsular,0.0011744290290882828
caps,0.0011744290290882828
capable,0.0011744290290882828
capability,0.0011744290290882828
nucleocapsid,0.0011744290290882828
encoded,0.0011744290290882828
predictors,0.0011744290290882828
pose,0.0011744290290882828
porphyria,0.0011744290290882828
polysorbate,0.0011744290290882828
polycythemia,0.0011744290290882828
poloxamer,0.0011744290290882828
pneumocystis,0.0011744290290882828
oxide,0.0011744290290882828
owing,0.0011744290290882828
cd14,0.0011744290290882828
cavity,0.0011744290290882828
patriarca,0.0011744290290882828
eot,0.0011744290290882828
gregory,0.0011744290290882828
epinephrine,0.0011744290290882828
enterocystoplasty,0.0011744290290882828
045,0.0011744290290882828
encephalopathy,0.0011744290290882828
vulnerable,0.0011744290290882828
gy,0.0011744290290882828
workshop,0.0011744290290882828
perinephric,0.0011744290290882828
pericardial,0.0011744290290882828
perfusion,0.0011744290290882828
caucasian,0.0011744290290882828
pectoral,0.0011744290290882828
peak,0.0011744290290882828
pbmcs,0.0011744290290882828
wish,0.0011744290290882828
window,0.0011744290290882828
wilcoxons,0.0011744290290882828
widal,0.0011744290290882828
whevener,0.0011744290290882828
xanthine,0.0011744290290882828
1981,0.0011744290290882828
parental,0.0011744290290882828
causative,0.0011744290290882828
peep,0.0011744290290882828
cd40l,0.0011744290290882828
epitopes,0.0011744290290882828
1x109,0.0011744290290882828
1g,0.0011744290290882828
1b,0.0011744290290882828
vera,0.0011744290290882828
empirically,0.0011744290290882828
embolism,0.0011744290290882828
ellenberg,0.0011744290290882828
vasopressin,0.0011744290290882828
vasectomized,0.0011744290290882828
causing,0.0011744290290882828
ehlers,0.0011744290290882828
checkpoints,0.0011744290290882828
changed,0.0011744290290882828
occurence,0.0011744290290882828
occupational,0.0011744290290882828
black,0.0011744290290882828
prescribing,0.0011744290290882828
premenopausal,0.0011744290290882828
online,0.0011744290290882828
chained,0.0011744290290882828
obesity,0.0011744290290882828
nutritional,0.0011744290290882828
variation,0.0011744290290882828
ophthalmic,0.0011744290290882828
opacities,0.0011744290290882828
opacification,0.0011744290290882828
oozing,0.0011744290290882828
elimination,0.0011744290290882828
ono,0.0011744290290882828
bosch,0.0011744290290882828
boost,0.0011744290290882828
book,0.0011744290290882828
bonne,0.0011744290290882828
bmdw,0.0011744290290882828
posteriori,0.0011744290290882828
cellulaire,0.0011744290290882828
ordinal,0.0011744290290882828
cerebrospinal,0.0011744290290882828
oliguria,0.0011744290290882828
pregelatinized,0.0011744290290882828
preferable,0.0011744290290882828
predisposition,0.0011744290290882828
problem,0.0011744290290882828
probenecid,0.0011744290290882828
probabilities,0.0011744290290882828
predictor,0.0011744290290882828
precipitating,0.0011744290290882828
practitioners,0.0011744290290882828
organized,0.0011744290290882828
manifestation,0.0011744290290882828
mandatory,0.0011744290290882828
managed,0.0011744290290882828
maladie,0.0011744290290882828
reinforced,0.0011744290290882828
rehospitalizations,0.0011744290290882828
lymph,0.0011744290290882828
dysgueusia,0.0011744290290882828
dusp,0.0011744290290882828
duct,0.0011744290290882828
dual,0.0011744290290882828
edentate,0.0011744290290882828
unexposed,0.0011744290290882828
uncertainty,0.0011744290290882828
fibrillation,0.0011744290290882828
fetal,0.0011744290290882828
fernand,0.0011744290290882828
feasible,0.0011744290290882828
conduction,0.0011744290290882828
maize,0.0011744290290882828
remissions,0.0011744290290882828
rely,0.0011744290290882828
pathogens,0.0011744290290882828
patches,0.0011744290290882828
unfit,0.0011744290290882828
completely,0.0011744290290882828
arthralgia,0.0011744290290882828
arising,0.0011744290290882828
arginine,0.0011744290290882828
ards,0.0011744290290882828
concurrently,0.0011744290290882828
confound,0.0011744290290882828
confirmatory,0.0011744290290882828
confined,0.0011744290290882828
mdw,0.0011744290290882828
maximal,0.0011744290290882828
fanconi,0.0011744290290882828
mannitol,0.0011744290290882828
facilitate,0.0011744290290882828
unresectable,0.0011744290290882828
unpublished,0.0011744290290882828
relies,0.0011744290290882828
relatively,0.0011744290290882828
marzouk,0.0011744290290882828
maria,0.0011744290290882828
margin,0.0011744290290882828
marfan,0.0011744290290882828
connective,0.0011744290290882828
conjugated,0.0011744290290882828
aptt,0.0011744290290882828
fall,0.0011744290290882828
calendar,0.0011744290290882828
pathologic,0.0011744290290882828
36v2tm,0.0011744290290882828
drb1,0.0011744290290882828
consults,0.0011744290290882828
constitutional,0.0011744290290882828
limb,0.0011744290290882828
aphtosis,0.0011744290290882828
aphtoid,0.0011744290290882828
apart,0.0011744290290882828
aortic,0.0011744290290882828
parvovirus,0.0011744290290882828
respected,0.0011744290290882828
loghr,0.0011744290290882828
contraceptionassociated,0.0011744290290882828
continuously,0.0011744290290882828
favourably,0.0011744290290882828
contribute,0.0011744290290882828
latex,0.0011744290290882828
reversible,0.0011744290290882828
enclosed,0.0011744290290882828
reticulocytopenia,0.0011744290290882828
restriction,0.0011744290290882828
li,0.0011744290290882828
anymore,0.0011744290290882828
enrolling,0.0011744290290882828
172,0.0011744290290882828
16s,0.0011744290290882828
res,0.0011744290290882828
reproducibility,0.0011744290290882828
representant,0.0011744290290882828
lungs,0.0011744290290882828
lpf,0.0011744290290882828
consequently,0.0011744290290882828
consequences,0.0011744290290882828
repercussions,0.0011744290290882828
macrogol,0.0011744290290882828
cardiological,0.0011744290290882828
fistulas,0.0011744290290882828
living,0.0011744290290882828
liters,0.0011744290290882828
linguistic,0.0011744290290882828
linearity,0.0011744290290882828
residuals,0.0011744290290882828
reset,0.0011744290290882828
researchers,0.0011744290290882828
pills,0.0011744290290882828
phlebotomies,0.0011744290290882828
phenytoin,0.0011744290290882828
carriers,0.0011744290290882828
lymphomas,0.0011744290290882828
2124,0.0011744290290882828
ranging,0.0011744290290882828
b19,0.0011744290290882828
avoided,0.0011744290290882828
avascular,0.0011744290290882828
raj,0.0011744290290882828
br3,0.0011744290290882828
boutboul,0.0011744290290882828
play,0.0011744290290882828
pao,0.0011744290290882828
panels,0.0011744290290882828
computing,0.0011744290290882828
optimizing,0.0011744290290882828
esomeprazole,0.0011744290290882828
experiencing,0.0011744290290882828
companies,0.0011744290290882828
community,0.0011744290290882828
colorectal,0.0011744290290882828
colony,0.0011744290290882828
mirtazapine,0.0011744290290882828
authorizing,0.0011744290290882828
attributable,0.0011744290290882828
rating,0.0011744290290882828
ranieri,0.0011744290290882828
paediatric,0.0011744290290882828
easy,0.0011744290290882828
easier,0.0011744290290882828
eac,0.0011744290290882828
expectancy,0.0011744290290882828
207,0.0011744290290882828
200mg,0.0011744290290882828
2d6,0.0011744290290882828
264,0.0011744290290882828
myeloblative,0.0011744290290882828
multicentricity,0.0011744290290882828
eradicated,0.0011744290290882828
eradicate,0.0011744290290882828
214,0.0011744290290882828
packages,0.0011744290290882828
pac02,0.0011744290290882828
p450,0.0011744290290882828
ozurdex,0.0011744290290882828
plasmablasts,0.0011744290290882828
mole,0.0011744290290882828
modifies,0.0011744290290882828
modifications,0.0011744290290882828
modeling,0.0011744290290882828
mo,0.0011744290290882828
quasi,0.0011744290290882828
25mmhg,0.0011744290290882828
paco2,0.0011744290290882828
mesenteric,0.0011744290290882828
mental,0.0011744290290882828
meningoencephalitis,0.0011744290290882828
members,0.0011744290290882828
melun,0.0011744290290882828
medullary,0.0011744290290882828
realized,0.0011744290290882828
realize,0.0011744290290882828
attempts,0.0011744290290882828
atherosclerosis,0.0011744290290882828
30min,0.0011744290290882828
meter,0.0011744290290882828
universitaire,0.0011744290290882828
universelle,0.0011744290290882828
e172,0.0011744290290882828
e171,0.0011744290290882828
dysregulated,0.0011744290290882828
mar,0.0011744290290882828
mapping,0.0011744290290882828
assessments,0.0011744290290882828
asplenia,0.0011744290290882828
aspects,0.0011744290290882828
ascent,0.0011744290290882828
artpo,0.0011744290290882828
3000,0.0011744290290882828
atelectasis,0.0011744290290882828
assumptions,0.0011744290290882828
av,0.0011744290290882828
miller,0.0011744290290882828
mid,0.0011744290290882828
mianserine,0.0011744290290882828
compatibility,0.0011744290290882828
matthieu,0.0011744290290882828
microsined,0.0011744290290882828
microangiopathic,0.0011744290290882828
uveal,0.0011744290290882828
urologic,0.0011744290290882828
faster,0.0011744290290882828
unsuitable,0.0011744290290882828
unstable,0.0011744290290882828
unresponsive,0.0011744290290882828
unresolved,0.0011744290290882828
exposing,0.0011744290290882828
expose,0.0011744290290882828
exploring,0.0011744290290882828
expired,0.0011744290290882828
regress,0.0011744290290882828
refrain,0.0011744290290882828
refers,0.0011744290290882828
assignee,0.0011744290290882828
ureteral,0.0011744290290882828
wang,0.001013435891451566
worthy,0.001013435891451566
woman,0.001013435891451566
ending,0.001013435891451566
enrol,0.001013435891451566
guide,0.001013435891451566
equation,0.001013435891451566
planning,0.001013435891451566
carrying,0.001013435891451566
ovarian,0.001013435891451566
pains,0.001013435891451566
censoring,0.001013435891451566
censored,0.001013435891451566
possibly,0.001013435891451566
opioid,0.001013435891451566
boulevard,0.001013435891451566
orr,0.001013435891451566
oestrogen,0.001013435891451566
precluding,0.001013435891451566
precision,0.001013435891451566
glomerulonephritis,0.001013435891451566
globally,0.001013435891451566
subpopulations,0.001013435891451566
accordingly,0.001013435891451566
desire,0.001013435891451566
hematocrit,0.001013435891451566
held,0.001013435891451566
sum,0.001013435891451566
susceptible,0.001013435891451566
immuno,0.001013435891451566
gel,0.001013435891451566
gastroenterology,0.001013435891451566
tomographic,0.001013435891451566
activities,0.001013435891451566
achieving,0.001013435891451566
derivatives,0.001013435891451566
subgroup,0.001013435891451566
strictly,0.001013435891451566
stratum,0.001013435891451566
stevens,0.001013435891451566
glucose,0.001013435891451566
snellen,0.001013435891451566
5d,0.001013435891451566
transcriptomic,0.001013435891451566
fulfilled,0.001013435891451566
fsh,0.001013435891451566
spermogram,0.001013435891451566
specimens,0.001013435891451566
species,0.001013435891451566
sonography,0.001013435891451566
immunosuppressives,0.001013435891451566
density,0.001013435891451566
dendritic,0.001013435891451566
actually,0.001013435891451566
opioids,0.001013435891451566
eq,0.001013435891451566
episodes,0.001013435891451566
episode,0.001013435891451566
venous,0.001013435891451566
estimates,0.001013435891451566
electrophoresis,0.001013435891451566
blinding,0.001013435891451566
obstructive,0.001013435891451566
nursing,0.001013435891451566
null,0.001013435891451566
primarily,0.001013435891451566
transverse,0.001013435891451566
transthoracic,0.001013435891451566
transformed,0.001013435891451566
transferrin,0.001013435891451566
shows,0.001013435891451566
simon,0.001013435891451566
influenza,0.001013435891451566
slicc,0.001013435891451566
sizes,0.001013435891451566
adjustment,0.001013435891451566
adjudication,0.001013435891451566
adhesive,0.001013435891451566
adequately,0.001013435891451566
countries,0.001013435891451566
fluids,0.001013435891451566
troponin,0.001013435891451566
48h,0.001013435891451566
sent,0.001013435891451566
selective,0.001013435891451566
intercurrent,0.001013435891451566
crossed,0.001013435891451566
serologies,0.001013435891451566
intention,0.001013435891451566
agreement,0.001013435891451566
interruption,0.001013435891451566
interpreted,0.001013435891451566
donation,0.001013435891451566
kept,0.001013435891451566
kawasaki,0.001013435891451566
tyndall,0.001013435891451566
tumour,0.001013435891451566
truncation,0.001013435891451566
corresponds,0.001013435891451566
isoniazid,0.001013435891451566
secondly,0.001013435891451566
scored,0.001013435891451566
journal,0.001013435891451566
investment,0.001013435891451566
introducing,0.001013435891451566
amenorrhea,0.001013435891451566
alternatively,0.001013435891451566
alteration,0.001013435891451566
financial,0.001013435891451566
fields,0.001013435891451566
droplet,0.001013435891451566
rnaemia,0.001013435891451566
antinuclear,0.001013435891451566
antigens,0.001013435891451566
anticoagulants,0.001013435891451566
rifampicin,0.001013435891451566
laws,0.001013435891451566
latest,0.001013435891451566
anonymous,0.001013435891451566
lactate,0.001013435891451566
corpuscular,0.001013435891451566
keratitis,0.001013435891451566
confounding,0.001013435891451566
uniform,0.001013435891451566
fev1,0.001013435891451566
febrile,0.001013435891451566
replication,0.001013435891451566
considers,0.001013435891451566
contain,0.001013435891451566
consultations,0.001013435891451566
resources,0.001013435891451566
ldh,0.001013435891451566
reticulocyte,0.001013435891451566
respective,0.001013435891451566
lh,0.001013435891451566
contained,0.001013435891451566
finite,0.001013435891451566
means,0.001013435891451566
meaning,0.001013435891451566
mcr,0.001013435891451566
falls,0.001013435891451566
extreme,0.001013435891451566
30g,0.001013435891451566
units,0.001013435891451566
regulations,0.001013435891451566
confirmation,0.001013435891451566
application,0.001013435891451566
magnesium,0.001013435891451566
lvef,0.001013435891451566
congenital,0.001013435891451566
esr,0.001013435891451566
vasoconstrictor,0.001013435891451566
variants,0.001013435891451566
biobanking,0.001013435891451566
obtaining,0.001013435891451566
bias,0.001013435891451566
betamethasone,0.001013435891451566
normalized,0.001013435891451566
proposal,0.001013435891451566
neuropathy,0.001013435891451566
myelitis,0.001013435891451566
prothrombin,0.001013435891451566
classified,0.001013435891451566
ratios,0.001013435891451566
availability,0.001013435891451566
minimize,0.001013435891451566
fatal,0.001013435891451566
meetings,0.001013435891451566
reasonable,0.001013435891451566
aseptic,0.001013435891451566
recoveries,0.001013435891451566
compute,0.001013435891451566
composed,0.001013435891451566
concerns,0.001013435891451566
refusal,0.001013435891451566
referred,0.001013435891451566
24h,0.001013435891451566
avoiding,0.001013435891451566
moment,0.001013435891451566
collections,0.001013435891451566
comorbidities,0.001013435891451566
comité,0.001013435891451566
combining,0.001013435891451566
auricular,0.001013435891451566
asthma,0.001013435891451566
variable,0.001013435891451566
20mg,0.001013435891451566
close,0.001013435891451566
muscular,0.001013435891451566
native,0.001013435891451566
mucosa,0.001013435891451566
mos,0.001013435891451566
ptt,0.001013435891451566
mononeuropathy,0.001013435891451566
questionaire,0.001013435891451566
multidisciplinary,0.001013435891451566
walk,0.001013435891451566
1994,0.001013435891451566
entering,0.001013435891451566
performing,0.001013435891451566
partners,0.001013435891451566
parity,0.001013435891451566
categories,0.001013435891451566
phenotype,0.001013435891451566
personnes,0.001013435891451566
personal,0.001013435891451566
periodic,0.001013435891451566
distance,0.001013435891451566
75475,0.001013435891451566
tachycardia,0.001013435891451566
sustaining,0.001013435891451566
dilatation,0.001013435891451566
greatly,0.001013435891451566
94,0.001013435891451566
harvest,0.001013435891451566
handling,0.001013435891451566
haemoglobin,0.001013435891451566
hads,0.001013435891451566
discontinue,0.001013435891451566
testosterone,0.001013435891451566
termination,0.001013435891451566
discharge,0.0008885599123427332
ab,0.0008885599123427332
c30,0.0008885599123427332
paper,0.0008885599123427332
persons,0.0008885599123427332
eortc,0.0008885599123427332
questions,0.0008885599123427332
qlq,0.0008885599123427332
radiological,0.0008885599123427332
monitored,0.0008885599123427332
make,0.0008885599123427332
purpose,0.0008885599123427332
reaches,0.0008885599123427332
autoantibodies,0.0008885599123427332
random,0.0008885599123427332
comorbidity,0.0008885599123427332
minor,0.0008885599123427332
easily,0.0008885599123427332
electronic,0.0008885599123427332
biology,0.0008885599123427332
sedimentation,0.0008885599123427332
sequentially,0.0008885599123427332
later,0.0008885599123427332
saturation,0.0008885599123427332
retinopathy,0.0008885599123427332
replaced,0.0008885599123427332
hospitalisation,0.0008885599123427332
description,0.0008885599123427332
depending,0.0008885599123427332
statistics,0.0008885599123427332
5l,0.0008885599123427332
immunization,0.0008885599123427332
involve,0.0008885599123427332
curve,0.0008885599123427332
checkpoint,0.0008885599123427332
indicating,0.0008885599123427332
ch50,0.0008885599123427332
charlson,0.0008885599123427332
stated,0.0008885599123427332
check,0.0008885599123427332
fresh,0.0008885599123427332
independently,0.0008885599123427332
tarte,0.0008885599123427332
c3,0.0008885599123427332
subgroups,0.0008885599123427332
subpopulation,0.0008885599123427332
abnormality,0.0008885599123427332
access,0.0008885599123427332
real,0.00078652880822522
cohorts,0.00078652880822522
detailed,0.00078652880822522
institut,0.00078652880822522
erythrocyte,0.00078652880822522
biomedical,0.00078652880822522
medications,0.0007002627388705406
medium,0.0007002627388705406
perform,0.0007002627388705406
refer,0.0007002627388705406
